TABLE OF CONTENTS

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
 
 
 
 
 
 
 
 
 
 
☒
 
 
Filed by the Registrant
 
 
 ☐
 
 
Filed by a Party other than the Registrant
 
 
 
 
 
 
 
 
 
 
Check the appropriate box:
☒
Preliminary Proxy Statement
 ☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
 ☐
Definitive Proxy Statement
 ☐
Definitive Additional Materials
 ☐
Soliciting Material Pursuant to § 240.14a-12
 
NEW AMERICA ACQUISITION I CORP.
 
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
 
Payment of Filing Fee (Check all boxes that apply)
☒
No fee required.
 ☐
Fee paid previously with preliminary materials.
 ☐
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

TABLE OF CONTENTS

PRELIMINARY PROXY STATEMENT
SUBJECT TO COMPLETION DATED NOVEMBER 20, 2026
NEW AMERICA ACQUISITION I CORP.
725 Fifth Avenue, 22nd Floor
 
New York, New York 10022
NOTICE OF 2026 ANNUAL MEETING OF SHAREHOLDERS
 
To Be Held on December 22, 2026
To the Shareholders of New America Acquisition I Corp.:
You are cordially invited to virtually attend the 2026 Annual Meeting of Shareholders (the “Annual Meeting”) of New America Acquisition I Corp., a Florida corporation (“New America,” “we,” “us,” “our,” or the “Company”). The meeting will be held on December 22, 2026, at 10 a.m. Eastern Time, exclusively by means of remote communication via live webcast at www.virtualshareholdermeeting.com/NWAX2026. The Annual Meeting is being held for the following purposes:
1.
Proposal 1 — The Director Election Proposal: To elect Ted McDonagh and Stefan C. Passantino to the Board of Directors of the Company (the “Board”), each to serve as a Class I director until the Company’s 2029 Annual Meeting of Shareholders, or until such director’s successor is duly elected and qualified, or until such director’s earlier death, resignation, retirement, disqualification or removal (“Proposal 1” or the “Director Election Proposal”);
2.
Proposal 2 — The Extension Amendment Proposal: To amend the Company’s Second Amended and Restated Articles of Incorporation (the “Articles”) in the form set forth in Annex A to the accompanying proxy statement (the “Extension Amendment”) to extend the date by which the Company must consummate an initial business combination from June 5, 2027 (or December 5, 2027 if the Company has executed a definitive agreement for an initial business combination by June 5, 2027) to June 3, 2028 (or December 3, 2028 if the Company has executed a definitive agreement for an initial business combination by June 3, 2028) (the “Extension,” and such later date, the “Extended Date”) (“Proposal 2” or the “Extension Amendment Proposal”);
3.
Proposal 3 — The Auditor Ratification Proposal: To ratify the selection by the Audit Committee of the Board of MaloneBailey, LLP (“MaloneBailey”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 (“Proposal 3” or the “Auditor Ratification Proposal”); and
4.
Proposal 4 — The Adjournment Proposal: To approve the adjournment of the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies if there are insufficient votes in favor of the Director Election Proposal, the Extension Amendment Proposal or the Auditor Ratification Proposal (“Proposal 4” or the “Adjournment Proposal” and, together with the foregoing, the “Proposals”).
These items of business are more fully described in the proxy statement (the “Proxy Statement”) accompanying this Notice (“Notice”). In addition to the foregoing, the Annual Meeting may include the transaction of any other business relating to the purpose or purposes stated in this Notice and the accompanying Proxy Statement that may be properly brought before the Annual Meeting or any continuation, adjournment or postponement thereof.
The Board has fixed the close of business on November 13, 2026 as the record date (the “Record Date”) for determining the shareholders entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. As of November 13, 2026, there were 37,300,000 shares of Class A common stock, par value $0.0001 per share (“Class A common stock”), and 12,500,000 shares of Class B common stock, par value $0.0001 per share (“Class B common stock” or “founder shares” and, together with the Class A common stock, the “common stock”), issued and outstanding.
In connection with the Extension Amendment Proposal, holders of shares of Class A common stock included in the units sold in our initial public offering (the “public shares” and such holders, the “public shareholders”) may elect to redeem all or a portion of their public shares for a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account established in connection with our initial public offering (the “Trust Account”), including interest

TABLE OF CONTENTS

(net of taxes payable), divided by the number of then-outstanding public shares, regardless of whether, or how, they vote on the Extension Amendment Proposal. To exercise redemption rights, you must tender your shares to our transfer agent no later than 5:00 p.m., Eastern Time, on December 18, 2026 (two business days before the Annual Meeting). See “Proposal 2 — The Extension Amendment Proposal — Redemption Rights.”
THE REDEMPTION RIGHTS INCLUDE THE REQUIREMENT THAT A BENEFICIAL HOLDER MUST IDENTIFY ITSELF IN WRITING TO THE COMPANY IN ORDER TO VALIDLY REDEEM ITS SHARES.
The Board unanimously recommends that you vote “FOR” each Class I director nominee (holders of Class B common stock only), “FOR” the Extension Amendment Proposal, “FOR” the Auditor Ratification Proposal and “FOR” the Adjournment Proposal.
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting to Be Held Virtually on December 22, 2026 at 10 a.m. Eastern Time at www.virtualshareholdermeeting.com/NWAX2026.
The Proxy Statement is available at www.proxyvote.com.
 
 
 
 
By Order of the Board of Directors
 
 
 
 
 
 
 
Kyle Wool
 
 
 
Chairman of the Board and Chief Executive Officer
 
 
 
New York, NY
 
 
 
     , 2026
 
 
 
 
 
 
 
Your vote is important. Whether or not you expect to attend the Annual Meeting, please complete, date, sign and return the enclosed proxy, or vote over the telephone or the Internet as instructed in these materials, as promptly as possible in order to ensure your representation at the meeting. Even if you have voted by proxy, you may still vote if you attend the virtual meeting. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the virtual meeting, you must obtain a proxy issued in your name from that record holder.

TABLE OF CONTENTS

TABLE OF CONTENTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
i

TABLE OF CONTENTS

PRELIMINARY PROXY STATEMENT
SUBJECT TO COMPLETION DATED NOVEMBER 20, 2026
NEW AMERICA ACQUISITION I CORP.
725 Fifth Avenue, 22nd Floor
 
New York, New York 10022
PROXY STATEMENT
FOR THE ANNUAL MEETING OF SHAREHOLDERS
 
To be held on December 22, 2026
QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING
Why am I receiving this Proxy Statement?
The Board is soliciting your proxy for use at the 2026 Annual Meeting of Shareholders (the “Annual Meeting”) of New America Acquisition I Corp., a Florida corporation (“New America,” “we,” “us,” “our,” or the “Company”), our first annual meeting of shareholders since our initial public offering. This Proxy Statement is first being mailed to shareholders on or about    , 2026. We are a blank check company incorporated in the State of Florida on May 28, 2025 for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “business combination”). On December 5, 2025, we consummated our initial public offering (the “IPO”) of 34,500,000 units (including 4,500,000 units issued upon full exercise of the underwriters’ over-allotment option) at $10.00 per unit, generating gross proceeds of $345,000,000. Each unit consists of one share of Class A common stock and one-half of one redeemable warrant, each whole warrant exercisable for one share of Class A common stock at $11.50 per share. Our units, Class A common stock and warrants are listed on the New York Stock Exchange (the “NYSE”) under the symbols “NWAXU,” “NWAX” and “NWAXW,” respectively.
What am I voting on?
There are four matters scheduled for a vote:
•
Proposal 1: To elect Ted McDonagh and Stefan C. Passantino to the Board of Directors of the Company (the “Board”), each to serve as a Class I director until the Company’s 2029 Annual Meeting of Shareholders, or until such director’s successor is duly elected and qualified, or until such director’s earlier death, resignation, retirement, disqualification or removal (“Proposal 1” or the “Director Election Proposal”);
•
Proposal 2: To amend the Company’s Second Amended and Restated Articles of Incorporation (the “Articles”) in the form set forth in Annex A to the Proxy Statement (the “Extension Amendment”) to extend the date by which the Company must consummate an initial business combination from June 5, 2027 (or December 5, 2027 if the Company has executed a definitive agreement for an initial business combination by June 5, 2027) to June 3, 2028 (or December 3, 2028 if the Company has executed a definitive agreement for an initial business combination by June 3, 2028) (the “Extension,” and such later date, the “Extended Date”) (“Proposal 2” or the “Extension Amendment Proposal”);
•
Proposal 3: To ratify the selection by the Audit Committee of the Board of MaloneBailey, LLP (“MaloneBailey”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 (“Proposal 3” or the “Auditor Ratification Proposal”); and
•
Proposal 4: To approve the adjournment of the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies if there are insufficient votes in favor of the Director Election Proposal, the Extension Amendment Proposal or the Auditor Ratification Proposal (“Proposal 4” or the “Adjournment Proposal” and, together with the foregoing, the “Proposals”).
How does the Board recommend that I vote on the proposals?
The Board recommends that you vote as follows:
•
“FOR” each of the nominees in Proposal 1: the Director Election Proposal;
•
“FOR” Proposal 2: the Extension Amendment Proposal;
1

TABLE OF CONTENTS

•
“FOR” Proposal 3: the Auditor Ratification Proposal; and
•
“FOR” Proposal 4: the Adjournment Proposal.
How do I attend the Annual Meeting?
In order to facilitate shareholder participation and save costs, the meeting will be held virtually on December 22, 2026, at 10 a.m. Eastern Time. There will not be a physical meeting. We have worked to offer the same participation opportunities as if you attended the Annual Meeting in person and hope the online format will allow more shareholders to participate by removing any barriers caused by travel requirements. You may attend the Annual Meeting online, including voting and submitting questions, at www.virtualshareholdermeeting.com/NWAX2026 by entering the 16-digit control number included on your Proxy Card. You should ensure you have a strong Internet connection wherever you intend to participate in the Annual Meeting. We encourage you to access the Annual Meeting before it begins. Online check-in will begin at 9:30 a.m. Eastern Time on the date of the Annual Meeting.
Our virtual meeting provider, Broadridge Financial Solutions, Inc., facilitates shareholders’ opportunity to ask questions before and during the meeting. The Annual Meeting site will provide shareholders with information regarding (i) time guidelines for their questions, rules around what types of questions are allowed, and rules for how questions and comments will be recognized and disclosed to meeting participants; and (ii) procedures for posting appropriate questions received during the meeting and our answers on our website as soon as practical after the meeting. Once you are logged into the Annual Meeting, you will be able to submit your questions directly to the Company. Our virtual meeting will be governed by our rules of conduct and procedures, which will be posted at www.virtualshareholdermeeting.com/NWAX2026 in advance of the Annual Meeting.
You may obtain instructions for how to access the Annual Meeting online at www.virtualshareholdermeeting.com/NWAX2026. If you encounter any difficulties accessing the virtual meeting during the check-in or meeting time or need support in addressing technical and logistical issues related to accessing the virtual meeting platform, a technical assistance phone number will be made available on the virtual meeting registration page at www.virtualshareholdermeeting.com/NWAX2026, 30 minutes prior to the start of the meeting.
Who can vote at the Annual Meeting?
Only shareholders of record at the close of business on November 13, 2026 (the “Record Date”) will be entitled to vote on the proposals being presented at the Annual Meeting. On the Record Date, there were 37,300,000 shares of Class A common stock, par value $0.0001 per share (“Class A common stock”), and 12,500,000 shares of Class B common stock, par value $0.0001 per share (“Class B common stock” and, together with the Class A common stock, the “common stock”), issued and outstanding and entitled to vote at the Annual Meeting. Article IV, Section 4.3(a)(iii) of our Articles provides that, prior to the closing of an initial business combination, the holders of Class B common stock have the exclusive right to elect, remove and replace any director, and the holders of Class A common stock have no right to vote on the election, removal or replacement of any director. All 12,500,000 outstanding shares of Class B common stock are held by our sponsor, New America Sponsor I LLC (the “Sponsor”). Accordingly, the Sponsor alone will determine the outcome of the Director Election Proposal. Holders of our common stock are entitled to vote on the Extension Amendment Proposal, the Auditor Ratification Proposal and the Adjournment Proposal.
Shareholder of Record: Shares Registered in Your Name
If on November 13, 2026, your shares were registered directly in your name with the Company’s transfer agent, Odyssey Transfer and Trust Company, then you are a shareholder of record. As a shareholder of record, you may vote by virtually attending the Annual Meeting and voting during the Annual Meeting or vote over the telephone or the Internet or by proxy card. Whether or not you plan to virtually attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted.
Beneficial Owner: Shares Registered in the Name of a Broker or Other Nominee
If on November 13, 2026, your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer, other similar organization, or other nominee, then you are the beneficial owner of shares held in “street name” and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered to be the shareholder of record for purposes of voting on the proposals being presented at the Annual
2

TABLE OF CONTENTS

Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to virtually attend the Annual Meeting. However, since you are not the shareholder of record, you may not vote your shares at the Annual Meeting unless you request and obtain a valid proxy from your broker or other agent.
Why is the Company proposing the Extension Amendment Proposal?
Our Articles currently require us to complete an initial business combination within 18 months from the closing of our initial public offering (the “IPO”), or within 24 months from the closing of the IPO if we have executed a definitive agreement for an initial business combination within 18 months from the closing of the IPO (the “Current Deadline Date”). As of the date of this Proxy Statement, we have not entered into a definitive agreement for an initial business combination. The Board believes that additional time may be needed to identify a suitable target, negotiate and execute a definitive agreement, prepare and file the required registration statement or proxy materials with the Securities and Exchange Commission (the “SEC”), obtain shareholder approval and satisfy closing conditions. The Board believes it is in the best interests of our shareholders to approve the Extension now, so that our public shareholders retain the opportunity to participate in a business combination.
You are not being asked to vote on a business combination at this time. If the Extension is implemented and you do not elect to redeem your public shares, provided that you are a shareholder on the record date for a meeting to consider the proposed business combination, you will retain the right to vote on a business combination when it is submitted to shareholders and the right to redeem your public shares for cash in the event a business combination is approved and completed or we have not consummated a business combination by the Extended Date.
What if another matter is properly brought before the meeting?
The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying Proxy Card to vote on those matters in accordance with their best judgment, subject to compliance with Rule 14a-4(c) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
How do I vote?
All shares represented by valid proxies that we receive through this solicitation, and that are not revoked, will be voted in accordance with your instructions on the Proxy Card or as instructed via the Internet or telephone. You may specify whether your shares should be voted for, against, or abstain with respect to each of the proposals. Voting by proxy will not affect your right to attend the Annual Meeting.
The procedures for voting are as follows:
Shareholder of Record: Shares Registered in Your Name
If you are a shareholder of record, you may vote by virtually attending the Annual Meeting and voting during the Annual Meeting, vote by proxy over the telephone, vote by proxy through the Internet or vote by proxy using a Proxy Card. Whether or not you plan to virtually attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still virtually attend the Annual Meeting and vote during the Annual Meeting even if you have already voted by proxy.
•
To vote using the Proxy Card, simply complete, sign and date the Proxy Card and return it promptly in the envelope provided. If you return your signed Proxy Card to us before the Annual Meeting, we will vote your shares as you direct.
•
To vote over the telephone, dial toll-free 1-800-690-6903 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and 16-digit control number included on your Proxy Card. Your telephone vote must be received by 11:59 p.m. Eastern Time on December 21, 2026 to be counted.
3

TABLE OF CONTENTS

•
To vote through the Internet, go to www.proxyvote.com to complete an electronic proxy card. You will be asked to provide the company number and 16-digit control number from your Proxy Card. Your Internet vote must be received by 11:59 p.m. Eastern Time on December 21, 2026 to be counted.
•
If you virtually attend the Annual Meeting, you can also vote during the Annual Meeting by visiting www.virtualshareholdermeeting.com/NWAX2026 and entering the 16-digit control number included on your Proxy Card (if you received a printed copy of the proxy materials).
Beneficial Owner: Shares Registered in the Name of Broker or Bank
If you are a beneficial owner of shares registered in the name of your broker, bank, or other nominee, you should have received voting instructions from that organization rather than from us. Simply follow the instructions in the voting instruction form to ensure that your vote is counted. To vote online at the Annual Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact your broker, bank or other agent to request a proxy form well in advance of the meeting.
How many votes do I have?
Only holders of Class B common stock as of November 13, 2026 are entitled to vote on the Director Election Proposal with each share of Class B common stock representing one vote. On each of the Extension Amendment Proposal, the Auditor Ratification Proposal and the Adjournment Proposal, you have one vote for each share of common stock you own as of November 13, 2026.
What vote is required to approve each Proposal?
 
 
 
 
 
 
 
 
 
 
Proposal
 
 
Vote Required
 
 
Abstentions / “Withhold”
 
 
Broker Non-Votes
1. Director Election Proposal
 
 
Plurality of the votes cast by holders of Class B common stock present or represented by proxy and entitled to vote
 
 
Do not count as votes cast and have no effect on the vote
 
 
Do not count as votes cast and have no effect on the vote
 
 
 
 
 
 
 
 
 
 
2. Extension Amendment Proposal
 
 
Affirmative vote of a majority of the shares entitled to be cast, i.e., a majority of all outstanding shares of Class A common stock and Class B common stock voting together
 
 
Same effect as a vote AGAINST
 
 
Same effect as a vote AGAINST
 
 
 
 
 
 
 
 
 
 
3. Auditor Ratification Proposal
 
 
Votes cast FOR exceed votes cast AGAINST
 
 
Do not count as votes cast and have no effect on the vote
 
 
Voted at broker’s discretion
 
 
 
 
 
 
 
 
 
 
4. Adjournment Proposal
 
 
Votes cast FOR exceed votes cast AGAINST
 
 
Do not count as votes cast and have no effect on the vote
 
 
Voted at broker’s discretion
 
 
 
 
 
 
 
 
 
 
The Proposals are separate and apart from each other with votes of each Proposal separately counted.
What happens if I do not vote?
Shareholder of Record: Shares Registered in Your Name
If you are a shareholder of record and do not vote by completing your Proxy Card, or by telephone, through the Internet, or by virtually attending the Annual Meeting and voting during the Annual Meeting, your shares will not be voted.
Beneficial Owner: Shares Registered in the Name of Broker or Other Nominee
If you are a beneficial owner and do not instruct your broker, bank, or other agent how to vote your shares, the question of whether your broker or nominee will still be able to vote your shares depends on whether the particular proposal is a “routine” matter. Under the rules of the New York Stock Exchange (“NYSE”), brokers, banks and other securities
4

TABLE OF CONTENTS

intermediaries that are subject to NYSE rules may use their discretion to vote your “uninstructed” shares on matters considered to be “routine” under NYSE rules but not with respect to “non-routine” matters. The Auditor Ratification Proposal and the Adjournment Proposal are considered to be “routine” under NYSE rules such that your broker, bank or other agent may vote your shares on such proposals in the absence of your voting instructions. The Director Election Proposal and the Extension Amendment Proposal are considered “non-routine” such that your broker, bank or other agent may not vote your shares on such proposals in the absence of your voting instructions.
What constitutes a quorum?
Under Article II, Section 2.4 of our Bylaws, a majority of the votes entitled to be cast at the meeting constitutes a quorum, except that when specified business is to be voted on by a class or series of stock voting as a class, the majority of the votes of such class or series entitled to be cast shall constitute a quorum of such class or series for the transaction of such business. Based on 49,800,000 shares of common stock outstanding as of November 13, 2026, 24,900,001 shares must be present virtually or by proxy to establish a quorum for Proposals 2, 3 and 4, and 6,250,001 shares of Class B common stock must be present virtually or by proxy to establish a quorum for Proposal 1. Abstentions and broker non-votes, if any, count as present for quorum purposes. If a quorum is not present, the chairman of the meeting may adjourn the meeting under Sections 2.4 and 2.6 of our Bylaws.
An inspector of elections appointed for the meeting will determine whether a quorum is present and will tabulate votes cast by proxy or at the meeting. If a quorum is not present, we expect to adjourn or postpone the Annual Meeting until we obtain a quorum.
How do the Sponsor and the Company’s directors and officers intend to vote?
The Sponsor, our directors and our officers are expected to vote all shares over which they have voting control “FOR” each nominee in Proposal 1 and “FOR” each of Proposals 2, 3 and 4. As of the Record Date, the Sponsor held 12,500,000 shares of Class B common stock and 600,000 shares of Class A common stock (“private shares”) underlying its private placement units, representing approximately 26.3% of the outstanding common stock. Because the Extension Amendment Proposal requires the affirmative vote of a majority of all 49,800,000 outstanding shares (24,900,001 shares), approval will require the affirmative vote of at least 11,800,001 shares held by persons other than the Sponsor.
If the Extension Amendment Proposal is approved, what happens next?
We will file the Extension Amendment with the Florida Department of State, Division of Corporations, and continue to seek to consummate an initial business combination by the Extended Date. Public shareholders who properly exercise redemption rights will receive their pro rata portion of the Trust Account promptly following the Annual Meeting, and the amount remaining in the Trust Account will be reduced accordingly. We will remain a reporting company under the Exchange Act, and expect our units, Class A common stock and warrants to remain listed on the NYSE. Notwithstanding shareholder approval, the Board retains the right to abandon and not implement the Extension Amendment at any time before it becomes effective.
What happens if the Extension Amendment Proposal is not approved?
If the Extension Amendment Proposal is not approved and we do not consummate an initial business combination by the Current Deadline Date, we will, pursuant to Section 9.2(d) of our Articles, (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter (and subject to lawfully available funds therefor), redeem 100% of the public shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (net of taxes payable and less up to $100,000 of such net interest to pay dissolution expenses), divided by the number of then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and the Board, liquidate and dissolve, subject in each case to our obligations under the Florida Business Corporation Act, as amended (the “FBCA”) to provide for claims of creditors and other requirements of applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless.
5

TABLE OF CONTENTS

Do I need to vote on the Extension Amendment Proposal to redeem my shares?
No. You may redeem your public shares whether you vote “FOR” or “AGAINST” the Extension Amendment Proposal, abstain or do not vote at all, so long as you hold public shares and follow the redemption procedures described in this Proxy Statement. Redemption payments will be made only if the Extension Amendment is approved and implemented.
How do I redeem my public shares?
You must (i) submit a written request to our transfer agent, Odyssey Transfer and Trust Company, that we redeem all or a portion of your public shares, identifying yourself as the beneficial holder and providing your legal name, telephone number and address, and (ii) tender or deliver your shares (and any certificates) to the transfer agent physically or electronically using The Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) system, in each case no later than 5:00 p.m., Eastern Time, on December 18, 2026 (two business days before the Annual Meeting), at the following address:
Odyssey Transfer and Trust Company
Attn: Client Services / SPAC Redemptions
860 Blue Gentian Road, Suite 320
Eagan, MN 55121
E-mail: redemptions@odysseytrust.com
Holders of units must separate the underlying public shares before exercising redemption rights. See “Proposal 2 — The Extension Amendment Proposal — Redemption Rights.”
Do I have appraisal or dissenters’ rights?
No. Based on Section 607.1302 of the FBCA, we do not believe that shareholders are entitled to appraisal or dissenters’ rights in connection with any of the Proposals.
What if I return a Proxy Card or otherwise vote but do not make specific choices?
If you voted by proxy without marking any voting selections, then the proxy holders will vote your shares as recommended by the Board on all matters presented in this Proxy Statement, and as the proxy holders may determine in their discretion with respect to any other matters properly presented for a vote at the Annual Meeting.
Who is paying for this proxy solicitation?
We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit proxies in person, by telephone or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners. The entire cost of soliciting proxies on behalf of the Board will be borne by the Company.
What does it mean if I receive more than one Proxy Statement and Proxy Card?
If you receive more than one Proxy Statement and Proxy Card, your shares may be registered in more than one name or in different brokerage accounts. Please follow the voting instructions on the Proxy Cards to ensure that all of your shares are voted. Remember, you may vote by telephone, Internet or by signing, dating and returning a Proxy Card, or by voting at the Annual Meeting.
Can I change my vote or revoke my proxy?
Shareholder of Record: Shares Registered in Your Name
Yes. You may change your vote or revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you may change your vote or revoke your proxy in any one of the following ways:
•
You may submit a properly completed Proxy Card with a later date.
•
You may grant a subsequent proxy by telephone or through the Internet.
•
You may send a timely written notice that you are revoking your proxy to New America at 725 Fifth Ave, 22nd Floor, New York, NY 10022.
6

TABLE OF CONTENTS

•
You may virtually attend the Annual Meeting and vote online during the Annual Meeting. Simply virtually attending the Annual Meeting will not, by itself, revoke your proxy. You must specifically request at the Annual Meeting that it be revoked.
Beneficial Owner: Shares Registered in the Name of Broker or Bank
If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank.
Your most current vote that is valid, whether by telephone, Internet or proxy card is the one that will be counted.
What are “broker non-votes”?
If you are a beneficial owner whose shares of record are held by a broker, you may instruct your broker how to vote your shares. If you do not give instructions to your broker, the broker will determine if it has the discretionary authority to vote on the particular matter. Under NYSE rules, brokers, banks and other securities intermediaries that are subject to NYSE rules may use their discretion to vote your “uninstructed” shares on matters considered to be “routine” under NYSE rules but not with respect to “non-routine” matters.
A broker non-vote occurs when a broker, bank or other agent has not received voting instructions from the beneficial owner of the shares and the broker, bank or other agent cannot vote the shares. Broker non-votes, if any, will be counted for purposes of calculating whether a quorum is present at the meeting, but will not be counted for purposes of determining the number of votes cast with respect to a particular proposal.
The Auditor Ratification Proposal and the Adjournment Proposal are considered to be “routine” under NYSE rules such that your broker, bank or other agent may vote your shares on such proposals in the absence of your voting instructions. The Director Election Proposal and the Extension Amendment Proposal are considered “non-routine” such that your broker, bank or other agent may not vote your shares on such proposals in the absence of your voting instructions. Therefore, it is important that you provide your voting instructions to your broker to ensure your vote is counted.
When are shareholder proposals and director nominations due for next year’s annual meeting?
Pursuant to Rule 14a-8 of the Exchange Act, to be considered for inclusion in next year’s proxy materials, your proposal must be submitted in writing by     (the 120th day before the anniversary of the date this Proxy Statement is first released to shareholders), to New America at 725 Fifth Avenue, 22nd Floor, New York, New York 10022. Such a proposal must satisfy the rules and regulations of the SEC. In order to avoid controversy, shareholders should submit proposals by means (including electronic) that permit them to prove the date of delivery. To comply with the universal proxy rules, shareholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than October 23, 2027.
In addition, our Bylaws require that we be given advance written notice for nominations for election to our Board and of other business that shareholders wish to present for consideration at an annual meeting of shareholders (other than those proposals of business intended to be included in our proxy statement in accordance with Rule 14a-8 under the Exchange Act). Under Sections 2.7(a) and 3.3 of our Bylaws, shareholder proposals and director nominations outside Rule 14a-8 must be received not later than the close of business on the 90th day, nor earlier than the close of business on the 120th day, before the anniversary of the Annual Meeting, that is, between August 24, 2027 and September 23, 2027; provided, however, that in the event that the annual meeting is more than 30 days before or more than 60 days after such anniversary date (or if no annual meeting was held in the preceding year), notice by the shareholder to be timely must be so delivered not earlier than the close of business on the 120th day before the meeting and not later than the later of (x) the close of business on the 90th day before the meeting or (y) the close of business on the 10th day following the day on which public announcement of the date of the annual meeting is first made by the Company.
Prior to our initial business combination, holders of our public shares will not have the right to recommend director candidates for nomination to our Board.
How can I find out the results of the voting at the Annual Meeting?
Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a Current Report on Form 8-K that we expect to file within four business days after the Annual Meeting. If final voting
7

TABLE OF CONTENTS

results are not available to us in time to file a Current Report on Form 8-K within four business days after the Annual Meeting, we intend to file a Current Report on Form 8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Current Report on Form 8-K to publish the final results.
What proxy materials are available on the Internet?
The Proxy Statement and Proxy Card are available at www.proxyvote.com.
8

TABLE OF CONTENTS

PROPOSAL 1
APPROVAL OF THE DIRECTOR ELECTION PROPOSAL
Overview
Our business and affairs are managed under the direction of our Board. Our Board currently consists of five directors, divided into three classes with staggered three-year terms in accordance with our Articles. Under our Articles, the term of the initial Class I directors expires at the Annual Meeting, the term of the initial Class II directors expires at our 2027 annual meeting of shareholders, and the term of the initial Class III directors expires at our 2028 annual meeting of shareholders. Successors to each class are elected for three-year terms. The current composition of the Board is as follows:
 
 
 
 
 
 
 
Class
 
 
Directors
 
 
Term Expires
Class I
 
 
Ted McDonagh and Stefan C. Passantino
 
 
The Annual Meeting
(first annual meeting of shareholders)
 
 
 
 
 
 
 
Class II
 
 
Luisa Ingargiola and Steven Scopellite
 
 
2027 annual meeting of shareholders
 
 
 
 
 
 
 
Class III
 
 
Kyle Wool
 
 
2028 annual meeting of shareholders
 
 
 
 
 
 
 
Kevin McGurn, formerly our Chief Executive Officer and a Class III director, resigned from both positions effective August 5, 2026, and the size of the Board was decreased from six to five directors.
Upon the recommendation of the nominating and corporate governance committee, the Board has nominated Ted McDonagh and Stefan C. Passantino for election as Class I directors, each to serve until the Company’s 2029 annual meeting of shareholders, or until such director’s successor is duly elected and qualified, or until such director’s earlier death, resignation, retirement, disqualification or removal. Each nominee has consented to being named in this Proxy Statement and to serve if elected. If either nominee becomes unable to serve, proxies will be voted for any substitute nominee designated by the Board, or the Board may reduce its size.
Information About the Director Nominees
 
 
 
 
 
 
 
 
 
 
 
 
 
Name
 
 
Age
 
 
Position
 
 
Director Since
 
 
Class
Ted McDonagh
 
 
54
 
 
Independent Director
 
 
December 2025
 
 
I
 
 
 
 
 
 
 
 
 
 
 
 
 
Stefan C. Passantino
 
 
60
 
 
Independent Director
 
 
February 2026
 
 
I
 
 
 
 
 
 
 
 
 
 
 
 
 
Ted McDonagh has served as a member of our Board since December 2025. Mr. McDonagh is Managing Director, Partner, and Private Wealth Advisor at Ashton Thomas, a leading diversified financial advisory firm that specializes in advising foundations, business entities, and affluent individuals and families, based in Scottsdale, AZ. Leveraging the knowledge and experience of an extended career in financial services, Mr. McDonagh and his team advise entrepreneurs, C-suite executives, family office clients, and retirement plans. Since August 2025, Mr. McDonagh has also served on the board of directors of Yorkville Acquisition Corp. (Nasdaq: YORKU), a special purpose acquisition company. Mr. McDonagh was previously with Alex. Brown, a division of Raymond James, where he was a member of the firm’s Chairman’s Council. He joined Alex. Brown in 2008 and served as an advisor to affluent clients throughout his tenure with the firm. Earlier in his career, Mr. McDonagh was an advisor with Lehman Brothers in New York. He is a graduate of the University of Delaware, from which he received a Bachelor of Science degree in political science and economics. We believe Mr. McDonagh is qualified to serve on our Board based on his expertise and extensive experience in financial advisory services.
Stefan C. Passantino has served as a member of our Board since February 2026. Mr. Passantino combines experience in logistics and manufacturing senior management as a part of a 35-year legal career as a private sector compliance and litigation counsel. Previously, he has been involved in the management of numerous companies across industry groups as outside counsel and a member of various boards of directors. Mr. Passantino has been an equity partner in several law firms including Arnall, Golden & Gregory, Dentons USA and Michael Best, LLP. From January 2017 through September, 2018, Mr. Passantino served as Deputy White House Counsel in the Trump Administration. Mr. Passantino
9

TABLE OF CONTENTS

is currently a director of the Gingrich Foundation, JFB Construction Holdings (Nasdaq: JFB), and Mercantile Ports & Logistics, Ltd. He has an undergraduate degree from Drew University and a law degree from Emory Law School. The Board believes that Mr. Passantino’s extensive experience in logistics and manufacturing senior management as well as in the legal field qualify him to serve as a director.
Continuing Directors
Luisa Ingargiola, age 59, has served as a director since December 2025. Since February 2026, Ms. Ingargiola has served as President of First American Defense AI company, a defense technology company. Since February 2017, Ms. Ingargiola has served as Chief Financial Officer of Avalon GloboCare Corp. (NASDAQ: ALBT), a publicly listed bio-tech health care company. Prior to joining Avalon GloboCare Corp., Ms. Ingargiola served as the Chief Financial Officer and Co-Founder of MagneGas Corporation, an alternative energy company, from 2007 to 2018. Ms. Ingargiola has also served as a director and audit committee chair for various over-the-counter, Nasdaq and NYSE traded companies. Ms. Ingargiola has served as a member of the board of directors and the audit committee chair of Core AI Holdings, Inc. (NASDAQ: CHAI) since October 2025, on the board of directors of D. Boral ARC Acquisition I Corp. (NASDAQ: BCARU), a special purpose acquisition company, and its audit committee since July 2025, as a member of the board of directors and the audit committee chair of Vision Marine Technologies, Inc. (NASDAQ: VMAR) since December 2020, as a member of the board of directors and the audit committee chair of Fusion Fuel Green PLC (Nasdaq: HTOO) since February 2025, and as a member of the board of directors and audit committee chair of BioCorRx Inc. (OTC: BICX) since April 2018. Ms. Ingargiola has served on the board of directors of Dragonfly Energy Holdings Corp. (NASDAQ: DFLI) since October 2022 and served on the board of directors of Dragonfly Energy Corp. from August 2021 to October 2022. Ms. Ingargiola also served as a member of the board of directors and as the audit committee chair for Progress Acquisition Corporation (NASDAQ: PGRWU) from November 2020 to February 2023, as a member of the board of directors and the audit committee chair for AgEagle Aerial Systems Inc. (NYSE American: UAVS) from May 2018 to November 2022, as the audit committee chair of Siyata Mobile (NASDAQ: SYTA) from December 2020 to December 2021, as a member of the board of directors for Xos, Inc. (NASDAQ: XOS) from March 2024 to June 2025, and as a member of the board of directors, the compensation committee chair and the audit committee chair for Electra Meccanica Vehicles Corp. (Nasdaq: SOLO) from March 2018 to March 2024. Ms. Ingargiola holds a Master of Health Administration from the University of South Florida and a B.S. in Finance from Boston University. The Board believes Ms. Ingargiola is qualified to serve on our Board based on her previous roles serving as chief financial officer for multiple companies and extensive experience serving on multiple boards of directors for Nasdaq and NYSE traded companies.
Steven Scopellite, age 61, has served as a director since December 2025. Mr. Scopellite is a seasoned technology, financial, and operational leader with extensive experience serving on public, private, and nonprofit boards. Mr. Scopellite has served as a director on the board of directors of OceanFirst Financial Corp. (Nasdaq: OCFC) since June 2019, as a founding board member and advisor to Brink Gaming AG (formerly known as Pledge Publishing), a video game publisher that connects the gaming industry with the emerging Web3 ecosystem, since May 2023, and as a board member of the Riverview Medical Center Foundation Board of Trustees from 2013 through 2025. Mr. Scopellite retired from Goldman Sachs in 2013 after nearly 30 years with the firm, culminating in his role as Global Chief Information Officer. During his tenure, he was instrumental in Goldman Sachs’ global expansion, leading the development of its world-class technology organization of 8,000 technologists across 22 locations, advancing electronic trading, and driving the firm’s entry into new markets. Mr. Scopellite graduated from Brooklyn College with a bachelor’s degree in computer science. The Board believes Mr. Scopellite is qualified to serve on our Board based on his extensive leadership experience across financial services, technology innovation, healthcare, education, and philanthropy.
Kyle Wool, age 49, has served as a director and Chairman of the Board since February 2026 and as our Chief Executive Officer since August 2026. Mr. Wool has served as the President of Dominari Holdings Inc. since July 2022 and a member of its board of directors since April 2021. He has also served as the Chief Executive Officer and Chairman of Dominari Securities LLC, a FINRA registered broker dealer and SEC registered investment advisor, since July 2022. Mr. Wool has served as Chairman and a member of the board of directors of American Ventures Acquisition Corp. I since February 27, 2026. Mr. Wool is the Chief Executive Officer of American Ventures Global X LP, a multi-strategy hedge fund. He boasts over 20 years in various aspects of global finance as a Managing Director of Oppenheimer & Co. and Head of The Professional Investors Group of Oppenheimer Asia LTD. from 2009 to 2013, and Executive Director at Morgan Stanley from May 2013 to January 2021. Mr. Wool is active in various philanthropic endeavors both domestically and abroad. He currently serves as a board member of LifeLine NY, board member of the
10

TABLE OF CONTENTS

CIRSD (Center for International Relations and Sustainable Development), and board member of Project Rousseau. Mr. Wool holds Series 7, 63, & 24 securities licenses. Mr. Wool holds a degree from the State University of New York at Binghamton. The Board believes that Mr. Wool’s extensive experience in banking and wealth management qualifies him to serve as a director of the Company.
Executive Officers
 
 
 
 
 
 
 
Name
 
 
Age
 
 
Position
Kyle Wool
 
 
49
 
 
Chairman of the Board and Chief Executive Officer
 
 
 
 
 
Tim S. Ledwick
 
 
69
 
 
Chief Financial Officer
 
 
 
 
 
Christopher Devall
 
 
44
 
 
Chief Operating Officer
 
 
 
 
 
 
 
Kyle Wool (see above).
Tim S. Ledwick, age 69, has served as our Chief Financial Officer since August 2026. He has served as Chief Financial Officer of Dominari Holdings Inc. (Nasdaq: DOMH) since October 2025, and previously served as a member of the board of directors of Dominari Holdings from July 2015 through September 2025, including as chair of its audit committee. Prior to his appointment as Chief Financial Officer of Dominari Holdings, Mr. Ledwick provided chief financial officer consulting services to WRAP Technologies, Inc. (Nasdaq: WRAP), a public safety technology and services company. From 2011 until 2022, Mr. Ledwick served as the Chief Financial Officer of SYFT, a private equity-backed company that provided software solutions and services to hospitals focused on reducing costs through superior inventory management practices, which was successfully sold to GHX in 2022. Since 2012, Mr. Ledwick has served on the board of directors and as chair of the audit committee of Telkonet, Inc., a smart energy management technology company. From 2002 through 2006, Mr. Ledwick was a member of the board of directors and Executive Vice President and Chief Financial Officer of Dictaphone Corporation, from 2001-2002, Mr. Ledwick was brought on as CFO to lead the restructuring efforts of Lernout & Hauspie Speech Products (L&H), a Belgium-based NASDAQ listed speech technology company, and from 1999 through 2001, he served as Chief Financial Officer of Cross Media Marketing Corp., a public company headquartered in New York City. Mr. Ledwick is a member of the Connecticut Society of Certified Public Accountants and received his B.B.A. in Accounting from The George Washington University and his M.S. in Finance from Fairfield University.
Christopher Devall, age 44, has served as our Chief Operating Officer since August 2026. He has served as Chief Operating Officer of Dominari Holdings since January 2023, and previously served as Dominari Holdings’ Vice President of Operations from July 2022 to January 2023 and as a member of its advisory board from April 2022 to June 2022. Mr. Devall has also served as Chief Executive Officer of SIM Acquisition Corp. I (Nasdaq: SIMAU, SIMA, SIMAW), a special purpose acquisition company, since January 2026. Prior to joining Dominari Holdings, Mr. Devall served as a senior operations department head in the U.S. Navy from February 2019 to June 2022 and as a senior operations department manager from April 2016 to January 2019. Mr. Devall is a retired military veteran and maintains active FINRA registration holding Series 7, 24 and 66 licenses. In addition to his executive responsibilities, Mr. Devall serves on the board of directors of Dominari Securities LLC, a FINRA member introducing broker-dealer and SEC-registered investment advisor. He received his Master of Business Administration from the University of Virginia Darden School of Business and holds a B.S. in Strategic Studies and Defense Analysis from Norwich University. He remains active in his community and supports various nonprofit organizations, including serving as a director of The Forge Christian Ministries and Secretary of the Dominari Charitable Foundation.
Advisory Board
We have established an advisory board, the role and functions of which will be determined by the Board from time to time. We currently expect our advisory board to, upon the request of the directors, provide its business insights when we assess potential business combination targets identified by us and as we work to create additional value in the business or businesses that we acquire. The role of the advisory board is consultative in nature to support our directors and officers in operating our business, and it will not perform managerial Board or committee functions. Members of the advisory board will not be subject to the fiduciary requirements to which our Board is subject, nor will advisory board members have any internal voting or decision making role, or any authority to act on our behalf. The Board is not required to follow any advice, comments or recommendations of the advisory board in relation to the matters described
11

TABLE OF CONTENTS

herein. However, we have agreed to consult with our advisory board prior to advancing our process with potential business combination targets. The consultation process we have agreed to is detailed below. We may modify or expand our roster of advisory board members as we source potential business combination targets or work to create value in the business or businesses that we acquire.
We have agreed that we shall notify (the “LOI Notice”) members of our advisory board of the identity of any target or counterparty (the “Potential Target”) that we intend to deliver a letter of intent (“LOI”) to regarding a potential business combination at least seven days prior to the date on which we expect to deliver such LOI to the Potential Target (such date, the “LOI Notice Date”). Members of our advisory board will within fourteen days of the LOI Notice Date notify (the “LOI Response”) us if the advisory board member intends to exercise the Resignation Right (as defined below) if we enter into a business combination with the Potential Target identified in the LOI Notice (the “Identified Target”). We have also agreed to notify the advisory board member at least fourteen days prior to the date on which we intend to publicly disclose such proposed business combination with the Identified Target (the “Notification Period”). During the Notification Period, a member of our advisory board will, regardless of the indication provided by the advisory board member in the LOI Response, have the right, exercisable in their sole discretion, to resign from our advisory board by providing written notice to us that the advisory board member has elected to resign from the advisory board as they do not support us entering into a business combination with the Identified Target (the “Resignation Right”). In the event the advisory board member elects to exercise their Resignation Right, we have agreed to include in our public disclosure regarding the business combination a statement that such advisory board member(s) resigned from our advisory board immediately prior to the execution of the definitive agreement related to the business combination with the Identified Target as they do not support such proposed business combination. Any advisory board member that exercises their Resignation Right, will be entitled to retain all founder shares held by such advisory board member as of the date such advisory board member exercises the Resignation Right subject to certain exceptions.
Donald J. Trump Jr. and Eric Trump currently serve on our advisory board.
Donald J. Trump Jr. is the Executive Vice President of The Trump Organization, responsible for overseeing the company’s extensive real estate portfolio, media and other business interests around the globe. Mr. Trump currently serves as a director of both Trump Media & Technology Group Corp. (Nasdaq: DJT) and PSQ Holdings, Inc. (NYSE: PSQH). Over the course of his career, Mr. Trump has played a critical role in the development of many of The Trump Organization’s most successful real estate projects and has helped expand the company’s business holdings around the world. In addition to his real estate interests, Mr. Trump is an accomplished and sought-after speaker. He has spoken extensively throughout the United States and internationally and maintains an influential social media presence. Mr. Trump received his bachelor’s degree in Finance and Real Estate from the Wharton School of Finance at the University of Pennsylvania.
Eric Trump is the President and CEO of the Trump Organization, where he oversees all aspects of the company’s global operations, growth strategy, and development initiatives. Responsible for the continued expansion of the Trump brand worldwide, he leads the organization’s real estate, hospitality, golf, licensing, and consumer businesses, directing design, construction, development, acquisitions, operations, marketing, and asset management. Under his leadership, the company has expanded its international footprint with more than 20 active developments, including some of the world’s most prestigious luxury hotels, golf destinations, residential towers, and mixed-use projects. An internationally recognized business leader, investor, and speaker, Eric is a frequent keynote presenter who addresses audiences around the world on business, entrepreneurship, finance, and emerging technologies. His investments span energy, cryptocurrency, artificial intelligence, robotics, and other various technologies, and he has played a leading role in some of the nation’s largest cryptocurrency ventures, establishing himself as a prominent voice in the digital asset industry. Eric is the author of Under Siege, at one time the #1 New York Times bestseller, and was one of the most visible advocates for his father and the Make America Great Again movement. A key strategist in three presidential campaigns, he is also a highly sought-after media commentator whose television and digital appearances reach millions worldwide. Committed to philanthropy from an early age, Eric has helped raise more than $60 million for St. Jude Children’s Research Hospital in the fight against pediatric cancer. A graduate of Georgetown University with degrees in Finance and Management, Eric resides in Florida with his wife, Lara, and their two children, Luke and Carolina.
Past performance of our management team or their respective affiliates is not a guarantee either (i) of success with respect to any business combination we may consummate or (ii) that we will be able to identify a suitable candidate for our initial business combination. You should not rely on the historical performance record of our management team or their affiliates as indicative of our future performance. Our officers and directors may have conflicts of interest with other entities to which they owe fiduciary or contractual obligations with respect to initial business combination
12

TABLE OF CONTENTS

opportunities. For a list of our officers and directors and entities for which a conflict of interest may or does exist between such persons and us, as well as the priority and preference that such entity has with respect to performance of obligations and presentation of business opportunities to us, please refer to the table and subsequent explanatory paragraph under “— Conflicts of Interest.”
Board Leadership Structure
Our Board recognizes that one of its key responsibilities is to evaluate and determine its optimal leadership structure so as to provide effective oversight of management. Our bylaws and corporate governance guidelines provide our Board with flexibility to combine or separate the positions of Chair of the Board and Chief Executive Officer. Our Board believes that our existing leadership structure, under which Mr. Kyle Wool serves as our Chief Executive Officer and Chairman of the Board, is effective and achieves the optimal governance model for us and for our shareholders.
Board Meetings and Committees
During our fiscal year ended December 31, 2025, our Board held [•] meetings (including regularly scheduled and special meetings) and acted by written consent five times. Each director attended at least 75% of the aggregate of (i) the total number of meetings of our Board held during the period for which he or she had been a director and (ii) the total number of meetings held by all committees of our Board on which he or she served during the periods that he or she served.
Although we do not have a formal policy regarding director attendance at annual meetings, it is our practice that directors and director nominees named in our proxy statement attend our annual shareholder meetings. We did not hold an annual meeting in fiscal year 2025.
Director Independence
Section 303A.01 of the NYSE Listed Company Manual requires that a majority of the Board be independent, subject to the phase-in period available to newly listed companies. The Board has determined that Luisa Ingargiola, Steven Scopellite, Ted McDonagh and Stefan C. Passantino are “independent directors” as defined in the NYSE listing standards and applicable SEC rules. Mr. Wool is not independent.
Committees of the Board of Directors
Our Board has established three standing committees: an audit committee, a compensation committee and a nominating and corporate governance committee. Subject to phase-in rules and a limited exception, the rules of the NYSE and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors. Subject to phase-in rules and a limited exception, the rules of the NYSE require that the compensation committee of a listed company be comprised solely of independent directors. Each committee operates under a charter that has been approved by our Board and has the composition and responsibilities described below. The charter of each committee is available on our website at www.newamericaacquisition.com. The information included on our website is not incorporated by reference into this Proxy Statement or in any other document we file with the SEC, and any references to our website are intended to be inactive textual references only.
Audit Committee
Our Board has established an audit committee. Luisa Ingargiola, Steven Scopellite and Ted McDonagh serve as the members of our audit committee. Under the NYSE listing standards and applicable SEC rules, we are required to have three members of the audit committee, all of whom must be independent. Luisa Ingargiola, Steven Scopellite and Ted McDonagh are each independent.
Luisa Ingargiola serves as the chair of the audit committee. Our Board has determined that Ms. Ingargiola’s simultaneous service on multiple company boards does not impair her ability to effectively serve on our audit committee. Each member of the audit committee is financially literate, and our Board has determined that Luisa Ingargiola qualifies as an “audit committee financial expert” as defined in applicable SEC rules.
We have adopted an audit committee charter, which details the principal functions of the audit committee, including:
•
assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent registered public accounting firm’s qualifications and independence, and (4) the performance of our internal audit function and independent registered public accounting firm;
13

TABLE OF CONTENTS

•
the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us;
•
pre-approving all audit and non-audit services to be provided by the independent registered public accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; reviewing and discussing with the independent registered public accounting firm all relationships the independent registered public accounting firm has with us in order to evaluate their continued independence;
•
setting clear policies for audit partner rotation in compliance with applicable laws and regulations;
•
obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent registered public accounting firm’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the independent registered public accounting firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;
•
meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent registered public accounting firm, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”;
•
reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and
•
reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.
Compensation Committee
Our Board has established a compensation committee. The members of our compensation committee are Steven Scopellite, Luisa Ingargiola and Ted McDonagh. Steven Scopellite serves as chair of the compensation committee. Under the NYSE listing standards and applicable SEC rules, we are required to have a compensation committee of at least two members, all of whom must be independent. Steven Scopellite, Luisa Ingargiola and Ted McDonagh are each independent. We have adopted a compensation committee charter, which details the principal functions of the compensation committee, including:
•
reviewing and approving on an annual basis the corporate goals and objectives relevant to our chief executive officer’s compensation, evaluating our chief executive officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our chief executive officer based on such evaluation;
•
reviewing and making recommendations to our Board with respect to the compensation, and any incentive compensation and equity-based plans that are subject to board approval of all of our other officers;
•
reviewing our executive compensation policies and plans;
•
implementing and administering our incentive compensation equity-based remuneration plans;
•
assisting management in complying with our proxy statement and annual report disclosure requirements;
•
approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees;
•
producing a report on executive compensation to be included in our annual proxy statement; and
•
reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.
The charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and is directly responsible for the appointment, compensation
14

TABLE OF CONTENTS

and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee considers the independence of each such adviser, including the factors required by NYSE and the SEC.
Nominating and Corporate Governance Committee
We have established a nominating and corporate governance committee of the Board. The members of our nominating and corporate governance committee are Steven Scopellite, Luisa Ingargiola and Ted McDonagh. Steven Scopellite serves as chair of the nominating and corporate governance committee. We have adopted a nominating and corporate governance committee charter, which details the purpose and responsibilities of the nominating and corporate governance committee, including:
•
identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria approved by the Board, and recommending to the Board candidates for nomination for appointment at the annual meeting of shareholders or to fill vacancies on the Board;
•
developing and recommending to the Board and overseeing implementation of our corporate governance guidelines;
•
coordinating and overseeing the annual self-evaluation of the Board, its committees, individual directors and management in the governance of the company; and
•
reviewing on a regular basis our overall corporate governance and recommending improvements as and when necessary.
The charter also provides that the nominating and corporate governance committee may, in its sole discretion, retain or obtain the advice of, and terminate, any search firm to be used to identify director candidates, and is directly responsible for approving the search firm’s fees and other retention terms.
We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for directors, the Board considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders. Prior to our initial business combination, holders of our public shares will not have the right to recommend director candidates for nomination to our Board.
Shareholder Recommendations and Nominations to the Board of Directors
Shareholders may submit recommendations for director candidates to the Company by sending the individual’s name, qualifications, and other information as set forth in our bylaws to our Corporate Secretary at 725 Fifth Avenue, 22nd Floor, New York, New York 10022, who will forward all recommendations to the Board or the nominating and corporate governance committee of the Board. The nominating and corporate governance committee of the Board will evaluate any candidates recommended by shareholders against the same criteria and pursuant to the same policies and procedures applicable to the evaluation of candidates proposed by directors or management.
Shareholder and Other Interested Party Communications
The Board provides to every shareholder and any other interested parties the ability to communicate with the Board as a whole, and with individual directors on the Board, through an established process for shareholder communication. For a communication directed to the Board as a whole, shareholders and other interested parties may send such communication to our Corporate Secretary at 725 Fifth Avenue, 22nd Floor, New York, New York 10022.
For a shareholder or other interested party desiring to communicate with an individual director in his or her capacity as a member of the Board, shareholders and other interested parties may send such communication to the attention of the individual director to our Corporate Secretary at 725 Fifth Avenue, 22nd Floor, New York, New York 10022.
Our Corporate Secretary, in consultation with appropriate members of our Board as necessary, will review all incoming communications and, if appropriate, all such communications will be forwarded to the appropriate member or members of our Board, or if none is specified, to the chairperson of our Board.
15

TABLE OF CONTENTS

Risk Management
Management is responsible for the day-to-day management of risks the Company faces, while our Board, as a whole and assisted by its committees, has responsibility for the oversight of risk management. In its risk oversight role, our Board has the responsibility to satisfy itself that the risk management processes designed and implemented by management are appropriate and functioning as designed.
Our Board is responsible for risk oversight. Our Board believes that it is essential for effective risk management and oversight that there be open communication between management and our Board. Our Board meets with our Chief Executive Officer and Chief Financial Officer and other members of the senior management team regularly, where, among other topics, they discuss strategy and risks facing the Company.
Our Audit Committee assists our Board in fulfilling its oversight responsibilities with respect to risk management in the areas of internal control over financial reporting, disclosure controls and procedures, and legal and regulatory compliance, and discusses with management and the independent auditor guidelines and policies with respect to risk assessment and risk management. Our Audit Committee also reviews our major financial risk exposures and the steps management has taken to monitor and control these exposures. Our Audit Committee also monitors certain key risks on a regular basis throughout the fiscal year, such as risk associated with internal control over financial reporting and liquidity risk. Our Compensation Committee assesses risks created by the incentives inherent in our compensation policies. Our Nominating and Corporate Governance Committee assists our Board in fulfilling its oversight responsibilities with respect to the management of risk associated with board organization, membership and structure and corporate governance. Our full Board also reviews strategic and operational risk in the context of reports from the management team, receives reports on all significant committee activities at regular meetings of our Board, and evaluates the risks inherent in significant transactions.
Compensation Committee Interlocks and Insider Participation
The members of our compensation committee are Steven Scopellite, Luisa Ingargiola and Ted McDonagh. None of our executive officers currently serves, or in the past year has served, as a member of the compensation committee of any entity that has one or more executive officers serving on our Board.
Clawback Policy
We have adopted a compensation recovery policy that is compliant with NYSE listing rules as required by the Dodd-Frank Act.
Code of Ethics
We have adopted a Code of Ethics applicable to our directors, officers and employees. You will be able to review this document by accessing our public filings at the SEC’s website at www.sec.gov. In addition, a copy of the Code of Ethics and the charters of the committees of our board of directors will be provided without charge upon request from us at 725 Fifth Avenue, 22nd Floor, New York, New York 10022. If we make any amendments to our Code of Ethics other than technical, administrative or other non-substantive amendments, or grant any waiver, including any implicit waiver, from a provision of the Code of Ethics applicable to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions requiring disclosure under applicable SEC or NYSE rules, we will disclose the nature of such amendment or waiver on our website at www.newamericaacquisition.com. The information included on our website is not incorporated by reference into this Proxy Statement or in any other document we file with the SEC, and any references to our website are intended to be inactive textual references only.
Conflicts of Interest
Decisions or transactions by directors involving a conflict of interest that are fair to the corporation are not void or voidable and are not grounds for equitable relief or an award of damages in a legal proceeding.
A director’s conflict of interest transaction is fair if:
•
the transaction is beneficial to the corporation and its shareholders, considering whether it is:
○
fair in terms of the director’s dealing with the corporation; and
16

TABLE OF CONTENTS

○
comparable to an arm’s length transaction.
In relation to the foregoing, our Articles provide that:
•
we renounce any interest or expectancy in, or being offered an opportunity to participate in, any business opportunities that are presented to us or our officers or directors or shareholders or affiliates thereof, including but not limited to, our initial shareholders and their affiliates, except as may be prescribed by any written agreement with us; and
•
our officers and directors will not be liable to our Company or our shareholders for monetary damages for breach of any fiduciary duty by reason of any of our activities or any of our initial shareholders or their affiliates to the fullest extent permitted by Florida law.
Certain of our officers and directors presently have, and any of them in the future may have fiduciary or contractual obligations to another entity pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he has then-current fiduciary or contractual obligations, he will honor these fiduciary obligations under applicable law. Our Articles provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his capacity as a director or officer of our Company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue.
In addition, members of our management team and our board of directors directly or indirectly own founder shares and, accordingly, may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.
Below is a table summarizing the entities to which our executive officers and directors currently have fiduciary duties or contractual obligations:
 
 
 
 
 
 
 
 
 
 
Individual
 
 
Entity
 
 
Entity’s Business
 
 
Affiliation
Kyle Wool
 
 
Dominari Holdings Inc.
 
 
Financial services holding company
 
 
President and Director
 
Dominari Securities
 
 
Investment banking and registered investment advisor
 
 
Chief Executive Officer
 
American Ventures Global X LP
 
 
Hedge fund
 
 
Chief Executive Officer
 
 
 
 
 
 
 
 
 
 
Luisa Ingargiola
 
 
D. Boral ARC Acquisition I Corp.
 
 
Blank check company
 
 
Director
 
Dragonfly Energy Holdings Corp.
 
 
Energy storage and battery technology
 
 
Director
 
Avalon GloboCare Corp.
 
 
Biotechnology
 
 
Chief Financial Officer
 
BioCorRx Inc.
 
 
Healthcare
 
 
Director and Audit Committee Chair
 
Vision Marine Technologies, Inc.
 
 
Electric outboard powertrain systems
 
 
Director and Audit Committee Chair
 
Fusion Fuel Green PLC
 
 
Energy fuel technology
 
 
Director and Audit Committee Chair
 
Core AI Holdings, Inc.
 
 
Mobile games developer and publisher
 
 
Director and Audit Committee Chair
 
First American Defense AI
 
 
Defense technology
 
 
President
 
 
 
 
 
 
 
 
 
 
Ted McDonagh
 
 
Yorkville Acquisition Corp.
 
 
Blank check company
 
 
Director
 
Ashton Thomas
 
 
Financial advisory firm
 
 
Managing Director and Partner
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17

TABLE OF CONTENTS

 
 
 
 
 
 
 
 
 
 
Individual
 
 
Entity
 
 
Entity’s Business
 
 
Affiliation
Steven Scopellite
 
 
OceanFirst Financial Corp.
 
 
Banking and financial services holding company
 
 
Director
 
Brink Gaming AG
 
 
Video game publisher
 
 
Director and Advisor
 
Riverview Medical Center Foundation
 
 
Charitable organization
 
 
Board member
 
 
 
 
 
 
 
 
 
 
Stefan C. Passantino
 
 
Miller Strategies
 
 
Strategic advisory firm
 
 
Principal
 
JFB Construction Holdings
 
 
Construction & Development
 
 
Director
 
Mercantile Ports & Logistics Limited
 
 
Port and logistics operator
 
 
Director
Tim Ledwick
 
 
Dominari Holdings Inc.
 
 
Holding Company
 
 
Chief Financial Officer
 
Telkonet, Inc.
 
 
Energy Management
 
 
Director and Audit Committee Chair
Christopher Devall
 
 
Dominari Holdings Inc.
 
 
Holding Company
 
 
Chief Operating Officer
 
Dominari Securities LLC
 
 
Investment banking and registered investment advisor
 
 
Director
 
SIM Acquisition Corp. I
 
 
Blank check company
 
 
Chief Executive Officer
 
 
 
 
 
 
 
 
 
 
In addition, our Sponsor and our officers and directors may sponsor or form other special purpose acquisition companies similar to ours or may pursue other business or investment ventures during the period in which we are seeking an initial business combination. As a result, our Sponsor, officers and directors could have conflicts of interest in determining whether to present business combination opportunities to us or to any other special purpose acquisition company with which they may become involved. Any such companies, businesses or investments may present additional conflicts of interest in pursuing an initial business combination target, which could materially affect our ability to complete our initial business combination.
Potential investors should also be aware of the following other potential conflicts of interest:
Our officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our officers are not obligated to contribute any specific number of hours per week to our affairs.
In the course of their other business activities, our officers and directors may become aware of investment and business opportunities which may be appropriate for presentation to us as well as the other entities with which they are affiliated, including Yorkville Acquisition Corp. D. Boral ARC Acquisition I Corp., SIM Acquisition Corp. I and American Ventures Acquisition Corp. I. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented. Please see the table directly above for a description of our management’s other affiliations.
Our initial shareholders purchased founder shares and private units. Our initial shareholders, officers, directors and members of our advisory board, pursuant to a letter agreement with us, and the representatives of the underwriters, pursuant to the underwriting agreement, have agreed to waive their redemption rights with respect to their founder shares, private shares and any public shares they may acquire during or after the IPO and the representatives of the underwriters pursuant to the underwriting agreement have agreed to waive their redemption rights with respect to their representative shares in connection with the completion of our initial business combination or otherwise. Additionally, our initial shareholders, officers, directors and members of our advisory board, pursuant to a letter agreement with us, and the representatives of the underwriters pursuant to the underwriting agreement and solely with respect to the representative shares, have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares, representative shares and the private shares if we fail to complete our initial business combination within the prescribed time frame, although they will be entitled to liquidating distributions from assets outside the trust account. If we do not complete our initial business combination within the prescribed time frame, the
18

TABLE OF CONTENTS

private units will expire worthless. Furthermore, our initial shareholders, officers, directors and members of our advisory board have agreed not to transfer, assign or sell any of their founder shares and any shares of Class A common stock issuable upon conversion thereof until the completion of our initial business combination. Because each of our officers and director nominees will own shares of common stock or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.
Our Sponsor and members of our management team directly or indirectly own our securities, and accordingly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. Our Sponsor has invested in us an aggregate of $6,025,000, comprised of the $25,000 purchase price for the founder shares (or $0.002 per share) and the $6,000,000 purchase price for the private units (or $10.00 per unit), which may be exercised on a cashless basis. Accordingly, our management team, which owns interests in our Sponsor, may be more willing to pursue a business combination with a riskier or less-established target business than would be the case if our sponsor had paid the same per share price for the founder shares as our public shareholders paid for their public shares and if our sponsor were required to pay cash to exercise the private warrants.
Certain members of our management team may receive compensation upon consummation of our initial business combination, and accordingly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as such compensation will not be received unless we consummate such business combination.
Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination.
In the event our Sponsor or members of our management team provide loans to us to finance transaction costs and/or incur expenses on our behalf in connection with an initial business combination, such persons may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as such loans may not be repaid and/or such expenses may not be reimbursed unless we consummate such business combination.
Similarly, if we agree to pay our Sponsor or a member of our management team a finder’s fee, advisory fee, consulting fee or success fee in order to effectuate the completion of our initial business combination, such persons may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as any such fee may not be paid unless we consummate such business combination.
We are not prohibited from pursuing an initial business combination with a company that is affiliated with our Sponsor, officers, directors or members of our advisory board, or completing the business combination through a joint venture or other form of shared ownership with our Sponsor, officers or directors; accordingly, such affiliated person(s) may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as such affiliated person(s) would have interests different from our public shareholders and would likely not receive any financial benefit unless we consummated such business combination.
We are not prohibited from pursuing an initial business combination with a company that is affiliated with our Sponsor, officers, directors, or members of our advisory board, or completing the business combination through a joint venture or other form of shared ownership with our Sponsor, officers or directors. In the event we seek to complete our initial business combination with a company that is affiliated (as defined in our Articles) with our Sponsor (including its members), officers or directors, we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions, stating that the consideration to be paid by us in such an initial business combination is fair to our company from a financial point of view. We are not required to obtain such an opinion in any other context.
Prior to or in connection with the completion of our initial business combination, there may be payment by the company to our Sponsor, officers or directors, advisory board members, or our or their affiliates, of a finder’s fee, advisory fee, consulting fee or success fee for any services they render in order to effectuate the completion of our initial business combination, which, if made prior to the completion of our initial business combination, will be paid from funds held outside the trust account.
We cannot assure you that any of the above-mentioned conflicts will be resolved in our or your favor.
19

TABLE OF CONTENTS

In the event that we submit our initial business combination to our public shareholders for a vote, our initial shareholders, officers, directors, members of our advisory board and the representatives of the underwriters, solely with respect to the representative shares, have agreed to vote their founder shares, representative shares and private shares, and they and the other members of our management team have agreed to vote their founder shares, private shares and any shares purchased during or after the offering in favor of our initial business combination, aside from shares they may purchase in compliance with the requirements of Rule 14e-5 under the Exchange Act, which would not be voted in favor of approving the business combination transaction.
Limitation on Liability and Indemnification of Officers and Directors
Our Articles provide that our officers and directors will be indemnified by us to the fullest extent authorized by Florida law, as it now exists or may in the future be amended. In addition, our Articles provide that our directors will not be personally liable for monetary damages to us for breaches of their fiduciary duty as directors, except to the extent such exemption from liability or limitation thereof is not permitted by the FBCA.
We have entered into agreements with our officers and directors to provide contractual indemnification in addition to the indemnification provided for in our Articles. Our bylaws also permit us to maintain insurance on behalf of any officer, director or employee for any liability arising out of his actions, regardless of whether Florida law would permit such indemnification. We have obtained a policy of D&O liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.
These provisions may discourage shareholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action, if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions.
We believe that these provisions, the D&O liability insurance policy and the indemnity agreements are necessary to attract and retain talented and experienced officers and directors.
Insider Trading Policy
We have adopted an insider trading policy which governs transactions in our securities by us and our directors, officers, employees, consultants, and contractors and is designed to promote compliance with insider trading laws, rules and regulations applicable to the Company. A copy of our insider trading policy is filed with our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 as Exhibit 19.1.
Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information
We do not grant equity awards to our executive officers or other employees of the Company and therefore do not have a policy regarding the timing of grants of option awards in relation to the disclosure of material non-public information by the Company.
Director and Executive Compensation
None of our executive officers or directors has received any cash compensation for services rendered to us. We pay $20,000 per month for office space and administrative services. From the listing of our securities on the NYSE until October 15, 2026, these fees were paid to the Sponsor under an administrative services agreement dated December 3, 2025, which was terminated on October 15, 2026. Since October 15, 2026, we have paid these fees to Dominari, an affiliate of certain of our officers and directors, under an Administrative Services Agreement dated October 15, 2026. Certain of our officers, independent directors and advisory board members have received indirect interests in founder shares through membership interests in the Sponsor, including 50,000 founder shares each for Luisa Ingargiola, Ted McDonagh, Steven Scopellite and Stefan C. Passantino; 150,000 founder shares for George O’Leary, our former Chief Financial Officer; and 1,000,000 founder shares for Kevin McGurn, our former Chief Executive Officer. Advisory board members Donald J. Trump Jr. and Eric Trump have received indirect interests in 2,000,000 and 3,000,000 founder shares, respectively. Kyle Wool has not received and will not receive compensation or founder shares through membership interests in the Sponsor for his services. We reimburse our officers and directors for out-of-pocket
20

TABLE OF CONTENTS

expenses incurred on our behalf. We may pay consulting, success, advisory or finder’s fees to the Sponsor, our officers or directors, or their affiliates, in connection with our initial business combination. As an emerging growth company and smaller reporting company, we provide scaled executive compensation disclosure.
After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting or management fees from the combined company. All of these fees will be disclosed to shareholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed initial business combination. We have not established any limit on the amount of such fees that may be paid by the post-business combination company to our directors or members of management. It is unlikely the amount of such compensation will be known at the time of the proposed initial business combination, because the directors of the post-business combination company will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined, or recommended to the Board for determination, by a compensation committee constituted solely of independent directors or by a majority of the independent directors on our Board.
We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our officers and directors that provide for benefits upon termination of employment.
Other Matters
The Director Election Proposal is separate from, and is not contingent upon, the Auditor Ratification Proposal, the Extension Amendment Proposal and the Adjournment Proposal.
Vote Required for Approval
Pursuant to our Articles, only holders of Class B common stock are entitled to vote on the Director Election Proposal. Directors are elected by a plurality of the votes cast by the shareholders present virtually or represented by proxy at the meeting and entitled to vote thereon. This means the two nominees receiving the most “FOR” votes will be elected. Shareholders may vote “FOR” or “WITHHOLD” with respect to each nominee. “WITHHOLD” votes and broker non-votes will have no effect on the outcome, although they will count toward the quorum. Because the Sponsor holds all 12,500,000 outstanding shares of Class B common stock and has indicated that it intends to vote “FOR” each nominee, the election of each nominee is assured if the Sponsor so votes.
Recommendation of the Board
THE BOARD UNANIMOUSLY RECOMMENDS THAT HOLDERS OF CLASS B COMMON STOCK VOTE “FOR” THE ELECTION OF EACH OF TED MCDONAGH AND STEFAN C. PASSANTINO AS CLASS I DIRECTORS.
21

TABLE OF CONTENTS

PROPOSAL 2
APPROVAL OF THE EXTENSION AMENDMENT PROPOSAL
Overview
We are proposing to amend our Articles, in the form set forth in Annex A, to extend the date by which we must consummate an initial business combination from June 5, 2027 (or December 5, 2027 if we have executed a definitive agreement for an initial business combination by June 5, 2027) to June 3, 2028 (or December 3, 2028 if we have executed a definitive agreement for an initial business combination by June 3, 2028). The Extension Amendment would also make conforming changes to the definition of “Deadline Date” used throughout our Articles. A copy of the proposed Extension Amendment is attached as Annex A.
Background
On December 5, 2025, we consummated our IPO of 34,500,000 units at $10.00 per unit, generating gross proceeds of $345,000,000. Simultaneously with the closing of the IPO, we completed the private sale of 600,000 units (the “private units”) at $10.00 per unit to the Sponsor, generating gross proceeds of $6,000,000. Upon the closing of the IPO and the private placement, $345,000,000 ($10.00 per unit) was placed in the Trust Account. Funds in the Trust Account are held in an interest-bearing demand deposit account. As of November 13, 2026, the Trust Account held $[•], and we had income tax payable of $[•] and [had not withdrawn any interest from the Trust Account to pay taxes]. Under Article IX, Section 9.1(b) of our Articles, other than the withdrawal of interest to pay taxes (less up to $100,000 interest to pay dissolution expenses), funds in the Trust Account (including the interest earned on the funds held in the Trust Account) may not be released until the earliest of (i) the completion of an initial business combination, (ii) the redemption of 100% of the public shares if we are unable to complete an initial business combination by the Current Deadline Date, and (iii) the redemption of shares in connection with a vote to modify the substance or timing of our obligation to redeem 100% of the public shares if we have not consummated an initial business combination by the Current Deadline Date, or with respect to any other provisions relating to shareholders’ rights or pre-initial business combination activity. As of the date of this Proxy Statement, we have not entered into a definitive agreement for an initial business combination.
Reasons for the Extension Amendment Proposal
Our Articles provide that we have until the Current Deadline Date to complete an initial business combination. The Board believes that the Current Deadline Date may not provide sufficient time to complete the identification, negotiation, SEC review, shareholder approval and closing process for a business combination. The Board believes that, given our expenditure of time, effort and money in pursuing a business combination, it is in the best interests of our shareholders to provide additional time for the Company to complete an initial business combination. The Board also considered that public shareholders who do not wish to remain invested during the extended period may redeem their public shares in connection with the Extension.
Our Articles provide that if any amendment is made to modify the substance or timing of our obligation to redeem 100% of the public shares if we have not consummated an initial business combination by the Current Deadline Date, public shareholders must be provided with the opportunity to redeem their public shares upon approval of such amendment. We believe these provisions were included to protect our shareholders from having to sustain their investments for an unreasonably long period if we fail to find a suitable business combination in the timeframe contemplated by our Articles.
NYSE Considerations
Section 102.06 of the NYSE Listed Company Manual requires that a special purpose acquisition company complete one or more business combinations within three years of listing its securities on the NYSE, or such shorter period as specified in its governing documents. The Extended Date of December 3, 2028 is within such three-year period. Failure to complete a business combination within the NYSE period would result in the NYSE commencing delisting proceedings.
If the Extension Amendment Proposal Is Approved
If approved, we will file the Extension Amendment with the Florida Department of State, Division of Corporations, and it will become effective upon filing. We will remain a reporting company under the Exchange Act and expect our units, Class A common stock and warrants to remain listed on the NYSE. The redemption of public shares will reduce the
22

TABLE OF CONTENTS

amount in the Trust Account and increase the percentage interest of the Sponsor and other holders of non-redeemable shares. Notwithstanding shareholder approval, the Board retains the right to abandon and not implement the Extension Amendment at any time before it becomes effective without further shareholder action.
You are not being asked to vote on a business combination at this time. If the Extension is implemented and you do not elect to redeem your public shares, provided that you are a shareholder on the record date for a meeting to consider the proposed business combination, you will retain the right to vote on a business combination when it is submitted to shareholders and the right to redeem your public shares for cash in the event a business combination is approved and completed or we have not consummated a business combination by the Extended Date.
If the Extension Amendment Proposal Is Not Approved
If the Extension Amendment Proposal is not approved and we do not consummate an initial business combination by the Current Deadline Date, we will, pursuant to Section 9.2(d) of our Articles, (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter (and subject to lawfully available funds therefor), redeem 100% of the public shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (net of taxes payable and less up to $100,000 of such net interest to pay dissolution expenses), divided by the number of then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and the Board, liquidate and dissolve, subject in each case to our obligations under the FBCA to provide for claims of creditors and other requirements of applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless.
In the event of a liquidation, the Sponsor, our officers and directors, and the representatives of the underwriters have waived their rights to liquidating distributions from the Trust Account with respect to their founder shares, private shares and representative shares, as applicable, although they will be entitled to liquidating distributions with respect to any public shares they hold. The Sponsor has agreed that it will be liable to us if and to the extent any claims by a third party (other than our independent auditors) for services rendered or products sold to us, or a prospective target business with which we have entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of liquidation, less taxes payable. This liability will not apply to any claims by a third party or prospective target who executed a waiver of rights to the Trust Account, or to claims under our indemnity of the underwriters. We have not asked the Sponsor to reserve for these obligations, and we believe the Sponsor’s only assets with respect to our Company are our securities.
Redemption Rights
If the Extension Amendment Proposal is approved and the Extension is implemented, each public shareholder may redeem all or a portion of its public shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable), divided by the number of then-outstanding public shares, in accordance with our Articles. Based on the amount in the Trust Account as of November 13, 2026 of $[•], less income tax payable of $[•], the redemption price would have been approximately $[•] per public share. The closing price of our Class A common stock on the NYSE on November 19, 2026 was $10.04. We cannot assure shareholders that they will be able to sell their shares in the open market, even if the market price per share is higher than the redemption price, as there may not be sufficient liquidity.
The 20% redemption limitation in Article IX, Section 9.2(c) of our Articles applies only to a shareholder vote on an initial business combination and does not apply to redemptions in connection with the Extension. The Sponsor, our officers, directors and advisory board members, and the representatives of the underwriters have agreed to waive their redemption rights with respect to their founder shares, private shares, representative shares and any public shares in connection with a shareholder vote to approve an amendment such as the Extension Amendment. The Class A common stock included in the private units is not entitled to redemption rights.
TO EXERCISE YOUR REDEMPTION RIGHTS, YOU MUST, NO LATER THAN 5:00 P.M., EASTERN TIME, ON DECEMBER 18, 2026 (TWO BUSINESS DAYS BEFORE THE ANNUAL MEETING), (I) SUBMIT A WRITTEN REQUEST TO OUR TRANSFER AGENT THAT WE REDEEM YOUR PUBLIC SHARES FOR CASH, IDENTIFYING YOURSELF AS THE BENEFICIAL HOLDER AND PROVIDING YOUR LEGAL NAME, PHONE NUMBER AND ADDRESS, AND (II) TENDER YOUR SHARES PHYSICALLY OR ELECTRONICALLY THROUGH DTC’S DWAC SYSTEM.
23

TABLE OF CONTENTS

The transfer agent’s address is:
Odyssey Transfer and Trust Company
Attn: Client Services / SPAC Redemptions
860 Blue Gentian Road, Suite 320
Eagan, MN 55121
E-mail: redemptions@odysseytrust.com
Electronic delivery through DWAC can be accomplished by contacting the transfer agent or your broker. Physical delivery may take significantly longer, and shareholders should generally allow at least two weeks to obtain physical certificates. There is a nominal cost associated with tendering, which brokers may pass on to the redeeming holder. Any request for redemption, once made, may be withdrawn at any time until the redemption deadline and thereafter with our consent. If the Extension Amendment Proposal is not approved or the Extension is abandoned, tendered shares will not be redeemed and will be returned promptly. We anticipate paying redeeming holders promptly after the Extension Amendment becomes effective. Public shareholders who do not redeem will retain the right to redeem their public shares in connection with any shareholder vote or tender offer relating to our initial business combination, or upon our liquidation if we fail to consummate a business combination by the Extended Date.
EACH HOLDER IS URGED TO CONSULT ITS TAX ADVISOR REGARDING THE TAX CONSEQUENCES OF EXERCISING REDEMPTION RIGHTS.
Interests of the Sponsor and Our Directors and Officers
When considering the Board’s recommendation, you should keep in mind that the Sponsor and our directors and officers have interests that may differ from, or be in addition to, yours. These interests include:
•
the Sponsor holds 12,500,000 founder shares purchased for $25,000 (approximately $0.002 per share) and 600,000 private units purchased for $6,000,000, all of which (other than any public shares) will expire worthless if we do not complete a business combination;
•
certain of our directors, officers and advisory board members hold indirect interests in founder shares through membership interests in the Sponsor;
•
non-managing investors in the Sponsor purchased, indirectly, 600,000 private units for $6,000,000, and received indirect interests in an aggregate of 5,000,000 founder shares for nominal consideration;
•
Kyle Wool, our Chairman and Chief Executive Officer, is President and a director of Dominari, and chief executive officer of Dominari Securities LLC, a representative of the underwriters in our IPO that received 1,100,000 representative shares; Tim S. Ledwick and Christopher Devall, our Chief Financial Officer and Chief Operating Officer, are the Chief Financial Officer and Chief Operating Officer of Dominari, respectively; and Dominari receives $20,000 per month from us under the Administrative Services Agreement dated October 15, 2026;
•
the Sponsor, its affiliates and our officers and directors will not be reimbursed for out-of-pocket expenses in excess of funds held outside the Trust Account unless we complete a business combination, and any working capital loans (up to $2,500,000 of which may be convertible into private units at $10.00 per unit) may not be repaid unless we complete a business combination;
•
the Sponsor’s indemnification obligations with respect to the Trust Account described above;
•
we may pay consulting, success, advisory or finder’s fees to the Sponsor, our officers, directors or advisory board members, or their affiliates, in connection with our initial business combination; and
•
our officers and directors are entitled to continued indemnification and coverage under our directors’ and officers’ liability insurance policy.
Other Matters
The Extension Amendment Proposal is separate from, and is not contingent upon, the Director Election Proposal, the Auditor Ratification Proposal and the Adjournment Proposal.
24

TABLE OF CONTENTS

Vote Required for Approval
Our Articles provide that no amendment to Article IX shall be effective prior to the consummation of an initial business combination unless approved by the affirmative vote of the majority of the shares entitled to be cast on the amendment. Holders of Class A common stock and Class B common stock vote together as a single class on this proposal. Abstentions and broker non-votes will have the same effect as a vote “AGAINST” the Extension Amendment Proposal.
Recommendation of the Board
After careful consideration of all relevant factors, the Board has determined that the Extension Amendment is advisable and in the best interests of the Company and its shareholders. The Board makes no recommendation as to whether you should redeem your public shares.
THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR” THE EXTENSION AMENDMENT PROPOSAL.
25

TABLE OF CONTENTS

MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR SHAREHOLDERS EXERCISING REDEMPTION RIGHTS
The following discussion is a summary of material U.S. federal income tax considerations for holders of the Class A common stock that exercise their redemption right and have their shares of Class A common stock redeemed for cash if the Extension Amendment Proposal is approved. This section applies only to investors that hold Class A common stock as capital assets for U.S. federal income tax purposes (generally, property held for investment). This discussion does not address all aspects of U.S. federal income tax consequences that may be relevant to a particular shareholder in light of its particular circumstances or status, including:
•
banks, financial institutions or financial services entities;
•
broker-dealers;
•
S corporations;
•
taxpayers that are subject to the mark-to-market accounting rules;
•
tax-exempt entities;
•
governments or agencies or instrumentalities thereof;
•
tax-qualified retirement plans;
•
insurance companies;
•
regulated investment companies or real estate investment trusts;
•
expatriates or former long-term residents or citizens of the United States;
•
persons that directly, indirectly, or constructively own or have owned 5% or more of our voting shares or 5% or more of the total value of all classes of our shares;
•
persons that acquired our securities pursuant to an exercise of employee share options or upon payout of a restricted stock unit, in connection with employee share incentive plans or otherwise as compensation or in connection with the performance of services;
•
persons that hold our securities as part of a straddle, constructive sale, hedging, conversion, synthetic security or other integrated or similar transaction;
•
persons subject to an alternative minimum tax;
•
persons whose functional currency is not the U.S. dollar;
•
“controlled foreign corporations”, “passive foreign investment companies” and corporations that accumulate earnings to avoid U.S. federal income tax;
•
“qualified foreign pension funds” (within the meaning of Section 897(l)(2) of the Code) and entities whose interests are held by qualified foreign pension funds; or
•
accrual method taxpayers that file applicable financial statements as described in Section 451(b) of the Code.
This discussion is based on current U.S. federal income tax laws as in effect on the date hereof, which is subject to change, possibly on a retroactive basis, which may affect the U.S. federal income tax consequences described herein. Furthermore, this discussion does not address any aspect of U.S. federal non-income tax laws, such as gift, estate or Medicare net investment income tax laws, Foreign Account Tax Compliance Act (except as otherwise discussed below), or state, local or non-U.S. laws. The Company has not sought, and the Company does not intend to seek, a ruling from the U.S. Internal Revenue Service (“IRS”) as to any U.S. federal income tax considerations described herein. The IRS may disagree with the discussion herein, and its determination may be upheld by a court. Moreover, there can be no assurance that future legislation, regulations, administrative rulings or court decisions will not adversely affect the accuracy of the statements in this discussion.
This discussion does not consider the U.S. federal income tax treatment of entities or arrangements treated as partnerships or other pass-through entities (including branches) for U.S. federal income tax purposes (any such entity or arrangement, a “Flow-Through Entity”) or investors that hold our Class A common stock through Flow-Through
26

TABLE OF CONTENTS

Entities. If a Flow-Through Entity is the beneficial owner of our Class A common stock, the U.S. federal income tax treatment of an investor holding our Class A common stock through a Flow-Through Entity generally will depend on the status of such investor and the activities of such investor and such Flow-Through Entity.
If you hold our Class A common stock through a Flow-Through Entity, we urge you to consult your tax advisor as to the particular U.S. federal income tax consequences of the exercise of your redemption rights.
THE FOLLOWING IS FOR INFORMATIONAL PURPOSES ONLY. EACH HOLDER IS URGED TO CONSULT ITS TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES TO SUCH HOLDER OF EXERCISING REDEMPTION RIGHTS, INCLUDING THE EFFECTS OF U.S. FEDERAL, STATE AND LOCAL AND NON-U.S. TAX LAWS.
For purposes of this discussion, because any unit consisting of one share of Class A common stock and one-half of one warrant (with a whole warrant representing the right to acquire one share of Class A common stock) is separable at the option of the holder, the Company is treating each share of Class A common stock and one-half of one warrant to acquire one share of Class A common stock held by a holder in the form of a single unit as separate instruments and is assuming that the unit itself will not be treated as an integrated instrument. The separation of a unit into one share of Class A common stock and one-half of one warrant, which must be completed prior to the exercise of redemption rights, generally should not be a taxable event for U.S. federal income tax purposes. This position is not free from doubt, and no assurance can be given that the IRS would not assert, or that a court would not sustain, a contrary position.
U.S. Federal Income Tax Considerations to U.S. Shareholders
This section is addressed to Redeeming U.S. Holders (as defined below) of Class A common stock that elect to have their Class A common stock redeemed for cash. For purposes of this discussion, a “Redeeming U.S. Holder” is a beneficial owner that so redeems its shares and is, for U.S. federal income tax purposes:
•
an individual who is a citizen or resident of the United States;
•
a corporation (or other entity that is treated as a corporation for U.S. federal income tax purposes) that is created or organized (or treated as created or organized) in or under the laws of the United States or any state thereof or the District of Columbia;
•
an estate the income of which is subject to U.S. federal income taxation regardless of its source; or
•
an entity treated as a trust if (1) a U.S. court is able to exercise primary supervision over the administration of such trust and one or more United States persons (within the meaning of the Code) have the authority to control all substantial decisions of the trust or (2) it has a valid election in place to be treated as a United States person.
Tax Treatment of the Redemption — In General
The U.S. federal income tax consequences to a Redeeming U.S. Holder of Class A common stock that exercises its redemption rights to receive cash in exchange for all or a portion of its Class A common stock will depend on whether the redemption qualifies as a sale of the Class A common stock redeemed under Section 302 of the Code or is treated as a distribution under Section 301 of the Code.
If the redemption qualifies as a sale or other disposition of such Redeeming U.S. Holder’s shares, such Redeeming U.S. Holder will generally be required to recognize gain or loss in an amount equal to the difference, if any, between the amount of cash received and the tax basis of the shares redeemed. Such gain or loss should be treated as capital gain or loss if such shares were held as a capital asset on the date of the redemption. Any such capital gain or loss generally will be long-term capital gain or loss if the Redeeming U.S. Holder’s holding period for such shares exceeds one year at the time of the redemption. A Redeeming U.S. Holder’s tax basis in such Redeeming U.S. Holder’s shares generally will equal the acquisition cost of such shares less any prior distributions treated as a return of capital.
Whether a redemption of the Class A common stock qualifies for sale treatment will depend largely on the total number of shares of our stock treated as held by the redeemed holder before and after the redemption (including any stock constructively owned by the holder as a result of owning warrants) relative to all of our shares outstanding both before and after the redemption. The redemption generally will qualify as a sale of such shares if the redemption either (i) is “substantially disproportionate” with respect to the Redeeming U.S. Holder, (ii) results in a “complete redemption” of such Redeeming U.S. Holder’s interest in the Company or (iii) is “not essentially equivalent to a dividend” with respect to such Redeeming U.S. Holder. These tests are explained more fully below.
27

TABLE OF CONTENTS

For purposes of such tests, a Redeeming U.S. Holder takes into account not only shares directly owned by such Redeeming U.S. Holder, but also shares that are constructively owned by such Redeeming U.S. Holder. A Redeeming U.S. Holder may constructively own, in addition to Class A common stock owned directly, stock owned by certain related individuals and entities in which such Redeeming U.S. Holder has an interest or that have an interest in such Redeeming U.S. Holder, as well as any shares such Redeeming U.S. Holder has a right to acquire by exercise of an option, which would generally include shares which could be acquired pursuant to the exercise of the public warrants.
The redemption generally will be “substantially disproportionate” with respect to a Redeeming U.S. Holder if the percentage of the Company’s outstanding voting shares that such Redeeming U.S. Holder directly or constructively owns immediately after the redemption is less than 80% of the percentage of the Company’s outstanding voting shares that such Redeeming U.S. Holder directly or constructively owned immediately before the redemption, and such Redeeming U.S. Holder immediately after the redemption actually and constructively owns less than 50% of the total combined voting power of the Company. There will be a complete redemption of such Redeeming U.S. Holder’s interest if either (i) all of the shares directly or constructively owned by such Redeeming U.S. Holder are redeemed or (ii) all of the shares directly owned by such Redeeming U.S. Holder are redeemed and such Redeeming U.S. Holder is eligible to waive, and effectively waives in accordance with specific rules, the attribution of the shares owned by certain family members and such Redeeming U.S. Holder does not constructively own any other shares. The redemption will not be essentially equivalent to a dividend if it results in a “meaningful reduction” of such Redeeming U.S. Holder’s proportionate interest in the Company. Whether the redemption will result in a “meaningful reduction” in such Redeeming U.S. Holder’s proportionate interest will depend on the particular facts and circumstances applicable to it. The IRS has indicated in a published ruling that even a small reduction in the proportionate interest of a small minority shareholder in a publicly held corporation that exercises no control over corporate affairs may constitute such a “meaningful reduction.”
If none of the above tests is satisfied, the redemption will be treated as a distribution with respect to the shares under Section 302(d) of the Code, in which case the Redeeming U.S. Holder will be treated as receiving a corporate distribution as discussed below. A Redeeming U.S. Holder should consult with its own tax advisors as to the tax consequences of a redemption.
Redemption of Class A Common Stock Treated as Corporate Distribution
If the redemption is treated as a corporate distribution, such distribution generally will constitute a dividend for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Any such dividends paid to a Redeeming U.S. Holder that is taxable as a corporation generally will qualify for the dividends received deduction if the requisite holding period is satisfied. With certain exceptions (including, but not limited to, dividends treated as investment income for purposes of investment interest deduction limitations), and provided certain holding period requirements are met, dividends paid to a non-corporate Redeeming U.S. Holder generally will constitute “qualified dividends” that will be subject to tax at reduced rates accorded to long-term capital gains. It is unclear whether the redemption rights with respect to the Class A common stock described in this proxy statement may prevent a Redeeming U.S. Holder from satisfying the applicable holding period requirements with respect to the dividends received deduction or the preferential tax rate on qualified dividend income, as the case may be.
Distributions in excess of current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the Redeeming U.S. Holder’s adjusted tax basis in such Redeeming U.S. Holder’s Class A common stock. Any remaining excess will be treated as gain realized on the sale or other disposition of such Redeeming U.S. Holder’s Class A common stock as discussed below. After the application of those rules, any remaining tax basis of the Redeeming U.S. Holder in the redeemed Class A common stock will be added to the Redeeming U.S. Holder’s adjusted tax basis in its remaining shares of our stock, or, if it has none, to the Redeeming U.S. Holder’s adjusted tax basis in its public warrants or possibly in other shares constructively owned by it.
Redemption of Class A Common Stock Treated as a Sale or Other Disposition
If the redemption qualifies as a sale or other disposition of the Class A common stock, a Redeeming U.S. Holder will generally recognize gain or loss in an amount equal to the difference between (i) the amount of cash received in such redemption and (ii) the Redeeming U.S. Holder’s adjusted tax basis in its Class A common stock so redeemed.
A Redeeming U.S. Holder’s adjusted tax basis in its Class A common stock generally will equal the Redeeming U.S. Holder’s acquisition cost for such Class A common stock less any prior distributions treated as a return of capital.
28

TABLE OF CONTENTS

Any such capital gain or loss will be long-term capital gain or loss if the Redeeming U.S. Holder’s holding period for the Class A common stock so disposed of exceeds one year at the time of the redemption. Long-term capital gain realized by a non-corporate Redeeming U.S. Holder generally will be taxable at a reduced rate. The deduction of capital losses is subject to limitations. However, it is unclear whether the redemption rights with respect to the Class A common stock described in this proxy statement may prevent a Redeeming U.S. Holder from satisfying the applicable holding period requirements for long-term capital gain or loss.
If a Redeeming U.S. Holder holds different blocks of Class A common stock (generally, shares of Class A common stock purchased or acquired on different dates or at different prices), such Redeeming U.S. Holder is urged to consult its tax advisors to determine how the above rules apply to such Redeeming U.S. Holder.
ALL REDEEMING U.S. HOLDERS ARE URGED TO CONSULT THEIR TAX ADVISORS AS TO THE TAX CONSEQUENCES TO THEM OF A REDEMPTION OF ALL OR A PORTION OF THEIR CLASS A COMMON STOCK PURSUANT TO AN EXERCISE OF REDEMPTION RIGHTS.
U.S. Federal Income Tax Considerations to Non-U.S. Shareholders
This section is addressed to Redeeming Non-U.S. Holders (as defined below) of Class A common stock that elect to have their shares redeemed for cash as described in the section entitled “Proposal 2 — The Extension Amendment Proposal — Redemption Rights”. For purposes of this discussion, a “Redeeming Non-U.S. Holder” is a beneficial owner (other than a Flow-Through Entity) of our Class A common stock that so redeems its Class A common stock and is not a Redeeming U.S. Holder.
Tax Treatment of the Redemption — In General
Except as otherwise discussed in this section, the characterization of a redemption for a Redeeming Non-U.S. Holder who elects to have its shares redeemed will generally be characterized in the same manner as a U.S. shareholder for U.S. federal income tax purposes. See the discussion above under “U.S. Federal Income Tax Considerations to U.S. Shareholders.”
Redeeming Non-U.S. Holders considering exercising their redemption rights are urged to consult their tax advisors as to whether the redemption of their shares will be treated as a sale or as a distribution under the Code, and whether they will be subject to U.S. federal income tax on any gain recognized or dividends received as a result of the redemption based upon their particular circumstances.
Because it may not be certain at the time a Redeeming Non-U.S. Holder’s Class A common stock is redeemed whether the redemption will be treated as a sale or as a corporate distribution, and because that determination will depend in part on the Redeeming Non-U.S. Holder’s particular circumstances, the applicable withholding agent may not be able to determine whether (or to what extent) a Redeeming Non-U.S. Holder is treated as receiving a dividend for U.S. federal income tax purposes. Accordingly, the applicable withholding agent may withhold tax at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty) on the gross amount of any cash paid to a Redeeming Non-U.S. Holder in redemption of its Class A common stock, unless the withholding agent has established procedures allowing Redeeming Non-U.S. Holders to certify that they are exempt from such withholding and the Redeeming Non-U.S. Holder so certifies. A Redeeming Non-U.S. Holder generally may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS.
Redemption of Class A Common Stock Treated as a Corporate Distribution
If the redemption is treated as a corporate distribution, such distribution generally will constitute a dividend for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles, and provided such dividends are not effectively connected with the Redeeming Non-U.S. Holder’s conduct of a trade or business within the United States, we will be required to withhold tax from the gross amount of the dividend at a rate of 30%, unless such Redeeming Non-U.S. Holder is eligible for a reduced rate of withholding tax under an applicable income tax treaty and provides proper certification of its eligibility for such reduced rate (usually on an IRS Form W-8BEN or W-8BEN-E). Distributions in excess of current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the Redeeming Non-U.S. Holder’s adjusted tax basis in such Redeeming Non-U.S. Holder’s Class A common stock. Any remaining excess will be treated as gain realized on the sale or other disposition of such Redeeming Non-U.S. Holder’s Class A common stock as discussed below.
29

TABLE OF CONTENTS

The withholding tax does not apply to dividends paid to a Redeeming Non-U.S. Holder who provides a Form W-8ECI, certifying that the dividends are effectively connected with the Redeeming Non-U.S. Holder’s conduct of a trade or business within the United States. Instead, the effectively connected dividends will be subject to regular U.S. income tax as if the Redeeming Non-U.S. Holder were a U.S. resident, subject to an applicable income tax treaty providing otherwise. A Redeeming Non-U.S. Holder that is a corporation receiving effectively connected dividends may also be subject to an additional “branch profits tax” imposed at a rate of 30% (or a lower treaty rate).
Redemption of Class A Common Stock Treated as a Sale or Other Disposition
If the redemption qualifies as a sale or other disposition of the Class A common stock, a Redeeming Non-U.S. Holder generally will not be subject to U.S. federal income or withholding tax in respect of gain recognized on a sale or other disposition of Class A common stock unless:
•
the gain is effectively connected with the conduct of a trade or business by the Redeeming Non-U.S. Holder within the United States (and, under certain income tax treaties, is attributable to a United States permanent establishment or fixed base maintained by the Redeeming Non-U.S. Holder);
•
the Redeeming Non-U.S. Holder is an individual present in the United States for 183 days or more in the taxable year of disposition and certain other conditions are met; or
•
we are or have been a “U.S. real property holding corporation” for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the period that the Redeeming Non-U.S. Holder held Class A common stock and our Class A common stock is not treated as regularly traded on an established securities market within the meaning of the applicable Treasury Regulations. There can be no assurance that Class A common stock will be treated as regularly traded on an established securities market for this purpose.
Unless an applicable treaty provides otherwise, gain described in the first bullet point above will be subject to tax at generally applicable U.S. federal income tax rates as if the Redeeming Non-U.S. Holder were a U.S. resident. Any gains described in the first bullet point above of a Redeeming Non-U.S. Holder that is a foreign corporation may also be subject to an additional “branch profits tax” at a 30% rate (or lower treaty rate). Gain described in the second bullet point above will be subject to a 30% U.S. federal income tax rate.
If the third bullet point above applies to a Redeeming Non-U.S. Holder, gain recognized by such holder on the disposition of the Class A common stock will be subject to tax at generally applicable U.S. federal income tax rates. We will be classified as a U.S. real property holding corporation if the fair market value of our “U.S. real property interests” equals or exceeds 50% of the sum of the fair market value of our worldwide real property interests plus our other assets used or held for use in a trade or business, as determined for U.S. federal income tax purposes. We believe that we are not, and have not been at any time since our formation, a U.S. real property holding corporation. However, this determination is factual in nature, and no assurance can be given that the Company is not and has not been a U.S. real property holding corporation.
If a Redeeming Non-U.S. Holder holds different blocks of Class A common stock (generally, shares of Class A common stock purchased or acquired on different dates or at different prices), such Redeeming Non-U.S. Holder is urged to consult its tax advisors to determine how the above rules apply to such Redeeming Non-U.S. Holder.
FATCA Withholding
Sections 1471 through 1474 of the Code and the Treasury Regulations and administrative guidance promulgated thereunder (commonly referred to as the “Foreign Account Tax Compliance Act” or “FATCA”) generally impose withholding at a rate of 30% on payments of dividends on our Class A common stock to “foreign financial institutions” (which is broadly defined for this purpose and in general includes investment vehicles) and certain other Non-U.S. entities unless various U.S. information reporting and due diligence requirements (generally relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfied, or an exemption applies (typically certified as to by the delivery of a properly completed IRS Form W-8BEN-E). The IRS has issued proposed regulations (on which taxpayers may rely until final regulations are issued) that would eliminate FATCA withholding requirements on payments of gross proceeds from sales or other disposition proceeds of our Class A common stock. If FATCA withholding is imposed, a beneficial owner that is not a foreign financial institution generally will be entitled to a refund of any amounts withheld by filing a U.S. federal income tax return (which may entail significant administrative burden). Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States
30

TABLE OF CONTENTS

governing FATCA may be subject to different rules. Holders of Class A common stock are urged to consult their tax advisors regarding the effects of FATCA on the redemption of their Class A common stock.
Backup Withholding
In general, proceeds received from the exercise of redemption rights will be subject to backup withholding for a non-corporate Redeeming U.S. Holder that:
•
fails to provide an accurate taxpayer identification number;
•
is notified by the IRS regarding a failure to report all interest or dividends required to be shown on his or her federal income tax returns; or
•
in certain circumstances, fails to comply with applicable certification requirements.
A Redeeming Non-U.S. Holder generally may eliminate the requirement for information reporting and backup withholding by providing certification of its non-U.S. status, under penalties of perjury, on a duly executed applicable IRS Form W-8 or by otherwise establishing an exemption.
Backup withholding is not an additional tax. Any amount withheld under these rules will be creditable against the Redeeming U.S. Holder’s or Redeeming Non-U.S. Holder’s U.S. federal income tax liability or refundable to the extent that it exceeds this liability, provided that the required information is timely furnished to the IRS and other applicable requirements are met.
As previously noted above, the foregoing discussion of material U.S. federal income tax consequences is included for general information purposes only and is not intended to be, and should not be construed as, legal or tax advice to any shareholder. We once again urge you to consult with your tax advisor to determine the particular tax consequences to you (including the application and effect of any U.S. federal, state, local or foreign income or other tax laws) of the receipt of cash in exchange for shares in connection with the Extension Amendment Proposal and any redemption of your Class A common stock.
31

TABLE OF CONTENTS

PROPOSAL 3
APPROVAL OF THE AUDITOR RATIFICATION PROPOSAL
Overview
Our audit committee has selected MaloneBailey, LLP as our independent registered public accounting firm to audit our financial statements for the fiscal year ending December 31, 2026. MaloneBailey has served as our independent registered public accounting firm since 2025 and audited our financial statements for the period from May 28, 2025 (inception) through December 31, 2025. Although ratification is not required by our Bylaws or otherwise, we are submitting the selection of MaloneBailey to our shareholders as a matter of good corporate governance. If shareholders do not ratify the selection, the audit committee will reconsider whether to retain MaloneBailey. Even if the selection is ratified, the audit committee may, in its discretion, appoint a different independent registered public accounting firm at any time if it determines that a change would be in the best interests of the Company and its shareholders. Representatives of MaloneBailey are expected to attend the Annual Meeting, will have an opportunity to make a statement if they wish, and will be available to respond to appropriate questions.
Fees Paid to the Independent Registered Public Accounting Firm
The following table presents fees paid to MaloneBailey for services rendered from May 28, 2025 (inception) through December 31, 2025.
 
 
 
 
 
 
 
Period from May 28, 2025 (inception)
through December 31, 2025
Audit Fees(1)
 
 
$103,000
Audit-Related Fees(2)
 
 
$—
Tax Fees(3)
 
 
$—
All Other Fees(4)
 
 
$—
Total
 
 
$103,000
 
 
 
 
(1)
Audit Fees consist of fees for professional services in connection with our IPO and the audit of our annual financial statements and reviews of our quarterly financial statements.
(2)
Audit-Related Fees consist of assurance and related services reasonably related to the audit or review of our financial statements. MaloneBailey did not render such services for the period from inception through December 31, 2025.
(3)
Tax Fees consist of tax compliance, tax advice and tax planning services.
(4)
All Other Fees consist of fees for all other services.
Pre-Approval Policy
Our audit committee was formed upon the consummation of our IPO. As a result, the audit committee did not pre-approve all of the foregoing services, although any services rendered prior to the formation of our audit committee were approved by our board of directors. Since the formation of our audit committee, and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the audit committee prior to the completion of the audit).
Other Matters
The Auditor Ratification Proposal is separate from, and is not contingent upon, the Director Election Proposal, the Extension Amendment Proposal and the Adjournment Proposal.
Vote Required for Approval
The Auditor Ratification Proposal will be approved if, at a meeting at which a quorum is present, the votes cast “FOR” the proposal exceed the votes cast “AGAINST” the proposal with holders of Class A common stock and Class B common stock voting together as a single class. Abstentions are not votes cast and will have no effect on the outcome. Because this proposal is considered a routine matter, brokers may vote uninstructed shares.
32

TABLE OF CONTENTS

Recommendation of the Board
THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR” THE RATIFICATION OF THE SELECTION OF MALONEBAILEY, LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
33

TABLE OF CONTENTS

REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
The audit committee has reviewed and discussed the audited financial statements for the period from inception through December 31, 2025 with our management. The audit committee has also reviewed and discussed with MaloneBailey, our independent registered public accounting firm, the matters required to be discussed by Auditing Standard No. 1301, Communications with Audit Committees, as adopted by the Public Company Accounting Oversight Board (“PCAOB”). The audit committee has also received the written disclosures and the letter from MaloneBailey required by applicable requirements of the PCAOB regarding the independent accountants’ communications with the audit committee concerning independence and has discussed with MaloneBailey the accounting firm’s independence. Based on the foregoing, the audit committee has recommended to our Board that the audited financial statements be included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and filed with the SEC.
Members of the Audit Committee
Luisa Ingargiola, Chair
Ted McDonagh
Steven Scopellite
The material in this report is not “soliciting material,” is not deemed “filed” with the SEC and is not to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended (“Securities Act”), or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
34

TABLE OF CONTENTS

PROPOSAL 4
AUTHORIZATION TO ADJOURN THE ANNUAL MEETING
Overview
The Adjournment Proposal, if approved, will allow the Board to adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation of proxies if, based upon the tabulated vote at the time of the Annual Meeting, there are insufficient votes in favor of the Director Election Proposal, the Extension Amendment Proposal or the Auditor Ratification Proposal. The Adjournment Proposal will be presented only if necessary. Separately, Section 2.6 of our Bylaws authorizes the chairman of the meeting to adjourn any meeting of shareholders from time to time, whether or not a quorum is present, and nothing in this proposal limits that authority.
Consequences if the Adjournment Proposal Is Not Approved
If the Adjournment Proposal is presented and not approved, the Board may not be able to adjourn the Annual Meeting by shareholder vote to solicit additional proxies, although the chairman of the meeting will retain the authority to adjourn under our Bylaws.
Other Matters
The Adjournment Proposal is separate from, and is not contingent upon, the Director Election Proposal, the Extension Amendment Proposal and the Auditor Ratification Proposal.
Vote Required for Approval
The Adjournment Proposal will be approved if the votes cast “FOR” the proposal exceed the votes cast “AGAINST” it with holders of Class A common stock and Class B common stock voting together as a single class. Abstentions are not votes cast and will have no effect on the outcome. Because this proposal is considered a routine matter, brokers may vote uninstructed shares.
Recommendation of the Board
THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR” THE ADJOURNMENT PROPOSAL.
35

TABLE OF CONTENTS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information regarding the ownership of our common stock as of November 13, 2026 by: (i) each director and nominee for director; (ii) each of our executive officers; (iii) all executive officers and directors as a group; and (iv) all those known by us to be beneficial owners of more than five percent of our common stock.
The percentages are based on 37,300,000 shares of Class A common stock and 12,500,000 shares of Class B common stock outstanding as of November 13, 2026. The table does not include shares of Class A common stock underlying warrants, as the warrants are not exercisable within 60 days.
 
 
 
 
 
 
 
 
 
 
 
 
 
Name and Address of Beneficial Owner(1)
 
 
Number of
Shares of Class A
Common Stock
 
 
Approximate
Percentage of
Shares of Class A
Common Stock
(%)
 
 
Number of
Shares of Class B
Common Stock
 
 
Approximate
Percentage of
Shares of Class B
Common Stock
(%)
Directors, Director Nominees, and Executive Officers:
 
 
 
 
 
 
 
 
 
 
 
 
Kyle Wool(2)
 
 
13,100,000
 
 
26.3%
 
 
12,500,000
 
 
100%
Tim S. Ledwick
 
 
—
 
 
—
 
 
—
 
 
—
Christopher Devall
 
 
—
 
 
—
 
 
—
 
 
—
Luisa Ingargiola(3)
 
 
50,000
 
 
*
 
 
50,000
 
 
*
Ted McDonagh(3)
 
 
50,000
 
 
*
 
 
50,000
 
 
*
Steven Scopellite(3)
 
 
50,000
 
 
*
 
 
50,000
 
 
*
Stefan C. Passantino(3)
 
 
50,000
 
 
*
 
 
50,000
 
 
*
All officers, directors and director nominees as a group (seven individuals)
 
 
13,100,000
 
 
26.3%
 
 
12,500,000
 
 
100%
5% Holders:
 
 
 
 
 
 
 
 
 
 
 
 
New America Sponsor I LLC(2)(4)(5)
 
 
13,100,000
 
 
26.3%
 
 
12,500,000
 
 
100%
Anson Funds Management LP(6)
 
 
2,968,491
 
 
8.0%
 
 
—
 
 
—
Washington Muse Investments SPC for and on behalf of Heraclitus SP(7)
 
 
2,950,000
 
 
7.9%
 
 
—
 
 
—
Harraden Circle Investments, LLC(8)
 
 
2,479,304
 
 
6.6%
 
 
—
 
 
—
HSBC Holdings PLC(9)
 
 
2,467,180
 
 
6.6%
 
 
—
 
 
—
 
 
 
 
 
 
 
 
 
 
 
 
 
*
Less than one percent.
(1)
Unless otherwise noted, the business address of each of the following is c/o New America Acquisition I Corp., 725 Fifth Avenue, 22nd Floor, New York, New York 10022.
(2)
New America Sponsor I LLC is the record holder of the 12,500,000 founder shares and 600,000 private shares. Kyle Wool is the manager of New America Sponsor I LLC and accordingly, Mr. Wool has voting and investment discretion with respect to the shares of common stock held of record by New America Sponsor I LLC. However, Mr. Wool does not have any direct economic interest in the shares held by New America Sponsor I LLC.
(3)
Interests shown consist solely of indirect membership interests in our Sponsor representing the indicated portion of founder shares, classified as shares of Class B common stock, held by our Sponsor. The founder shares represented thereby will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of our initial business combination or such earlier time at the option of the holder on a one-for-one basis, subject to adjustment.
(4)
Interests shown consist solely of 12,500,000 founder shares, classified as shares of Class B common stock, and 600,000 private shares, which are classified as shares of Class A common stock. The founder shares will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of our initial business combination or such earlier time at the option of the holder on a one-for-one basis, subject to adjustment.
(5)
The non-sponsor investors have purchased, through the purchase of non-managing sponsor membership interests, an aggregate of 600,000 private placement units at a price of $10.00 per unit ($6,000,000 in the aggregate). The sponsor issued membership interests at a nominal purchase price to the non-sponsor investors at the closing of the IPO reflecting indirect interests in an aggregate of 5,000,000 founder shares held by sponsor. The non-sponsor investors are not granted any shareholder or other rights in addition to those afforded to our other public shareholders, and are only issued membership interests in the sponsor, with no right to control the sponsor or vote or dispose of any securities held by the sponsor, including the founder shares and private placement units held by the sponsor.
(6)
Based on Schedule 13G filed on February 17, 2026 by Anson Funds Management LP (d/b/a Anson Funds), a Texas limited partnership, Anson Management GP LLC, a Texas limited liability company, Mr. Tony Moore, the principal of Anson Funds Management LP and Anson Management GP LLC, Anson Advisors Inc., an Ontario, Canada corporation, Mr. Amin Nathoo, a director of Anson Advisors Inc., and Mr. Moez Kassam, a director of Anson Advisors Inc., Anson Funds Management LP and Anson Advisors Inc. serve as co-investment advisors to the funds and may direct the vote and disposition of the 2,968,491 units held by the funds. As the general partner of Anson Funds Management LP, Anson Management GP LLC may
36

TABLE OF CONTENTS

direct the vote and disposition of the 2,968,491 units held by the funds. As the principal of Anson Funds Management LP and Anson Management GP LLC, Mr. Moore may direct the vote and disposition of the 2,968,491 units held by the funds. As directors of Anson Advisors Inc., Mr. Nathoo and Mr. Kassam may each direct the vote and disposition of the 2,968,491 units held by the funds. For Anson Funds Management LP, Anson Management GP LLC and Mr. Moore, the address is 16000 Dallas Parkway, Suite 800 Dallas, Texas 75248. For Anson Advisors Inc., Mr. Nathoo and Mr. Kassam, the address is 181 Bay Street, Suite 4200 Toronto, ON M5J 2T3.
(7)
Based on Schedule 13G filed on December 11, 2025, Washington Muse Investments SPC for and on behalf of Heraclitus SP has shared voting and dispositive power over 2,950,000 units. The principal business address of Washington Muse Investments SPC for and on behalf of Heraclitus SP is 190 Elgin Avenue George Town Grand Cayman KY1-9008 Cayman Islands.
(8)
Based on Schedule 13G/A filed on August 14, 2026, Harraden GP is the general partner to Harraden Fund, Harraden Special Op Fund, Harraden Strategic Fund, and Harraden Concentrated Fund, and Harraden LLC is the general partner of Harraden GP. Harraden Adviser serves as investment manager to Harraden Fund, Harraden Special Op Fund, Harraden Strategic Fund, Harraden Concentrated Fund, and other high net worth individuals. Mr. Fortmiller is the managing member of each of Harraden LLC and Harraden Adviser. In such capacities, each of Harraden GP, Harraden LLC, Harraden Adviser and Mr. Fortmiller may be deemed to indirectly beneficially own the shares reported therein directly beneficially owned by Harraden Fund, Harraden Special Op Fund, Harraden Strategic Fund, and Harraden Concentrated Fund. The principal business address of the reporting persons is 885 Third Avenue, Suite 2600B, New York, NY 10022.
(9)
Based on Schedule 13G filed on October 30, 2026. The principal business address of the reporting persons is 8 Canada Square, London E14 5HQ, United Kingdom.
New America Sponsor I LLC, our Sponsor, and our officers and directors are deemed to be our “promoters” as such term is defined under the federal securities laws.
37

TABLE OF CONTENTS

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
The following is a summary of transactions since May 28, 2025 (inception) to which we have been a participant, in which the amount involved exceeded the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed fiscal years, and in which any of our directors, executive officers, director nominees, holders of more than 5% of our capital stock, or their immediate family members had or will have a direct or indirect material interest, as required by Item 404 of Regulation S-K.
•
Founder Shares. On May 28, 2025, the Sponsor purchased 12,500,000 shares of Class B common stock for an aggregate purchase price of $25,000.
•
Private Placement. Simultaneously with the closing of the IPO, the Sponsor purchased 600,000 private units at $10.00 per unit, or $6,000,000. Non-sponsor investors purchased the private units indirectly through non-managing membership interests in the Sponsor and received indirect interests in an aggregate of 5,000,000 founder shares for a nominal purchase price.
•
Sponsor Promissory Note. On June 5, 2025, we issued an unsecured, non-interest-bearing promissory note to the Sponsor for borrowings of up to $350,000 to pay IPO-related costs. The note was repaid in full upon the closing of the IPO.
•
Administrative Services. Beginning on the date our securities were first listed on the NYSE, we paid the Sponsor $20,000 per month for office space, administrative services and compensation for sponsor officer time under an administrative services agreement dated December 3, 2025, which also provides for our indemnification of the Sponsor. That agreement was terminated on October 15, 2026 under a Termination and Release Agreement. On October 15, 2026, we entered into an Administrative Services Agreement with Dominari Holdings Inc. (“Dominari”), an affiliate of certain of our officers and directors, under which Dominari provides office space and administrative services for $20,000 per month until the earlier of our initial business combination and our liquidation.
•
Representative Shares. Upon consummation of the IPO, we issued 1,100,000 shares of Class A common stock to each of Dominari Securities LLC and D. Boral Capital LLC, or their designees (2,200,000 shares in aggregate, with a fair value of $22,000,000), as representative compensation. Dominari Securities LLC is an affiliate of Dominari, of which Kyle Wool is President and a director.
•
Registration Rights. We are party to a Registration Rights Agreement dated December 3, 2025 with the Sponsor and other holders, which provides customary demand and piggy-back registration rights.
•
Working Capital Loans. The Sponsor, its affiliates or our officers and directors may, but are not obligated to, loan us funds on a non-interest basis to finance transaction costs. Up to $2,500,000 of such loans may be convertible into private units at $10.00 per unit.
•
Indemnification. We have entered into indemnification agreements with our officers and directors and maintain directors’ and officers’ liability insurance.
38

TABLE OF CONTENTS

RELATED PARTY TRANSACTION POLICY
The audit committee has adopted a policy setting forth the policies and procedures for its review and approval or ratification of “related party transactions.” A “related party transaction” is any consummated or proposed transaction or series of transactions: (i) in which the Company was or is to be a participant; (ii) the amount of which exceeds (or is reasonably expected to exceed) the lesser of $120,000 or 1% of the average of the Company’s total assets at year-end for the prior two completed fiscal years in the aggregate over the duration of the transaction (without regard to profit or loss); and (iii) in which a “related party” had, has or will have a direct or indirect material interest. “Related parties” under this policy include: (i) our directors, nominees for director or officers or any person who has served in such roles since the beginning of the most recent fiscal year, even if he or she does not currently serve in that role; (ii) any record or beneficial owner of more than 5% of any class of our voting securities; (iii) any immediate family member of any of the foregoing if the foregoing person is a natural person; and (iv) any other person who may be a “related person” pursuant to Item 404 of Regulation S-K under the Exchange Act.
Pursuant to the policy, the audit committee considers (i) the relevant facts and circumstances of each related party transaction, including if the transaction is on terms comparable to those that could be obtained in arm’s-length dealings with an unrelated third party, (ii) the extent of the related party’s interest in the transaction, (iii) whether the transaction contravenes our code of ethics or other policies, (iv) whether the audit committee believes the relationship underlying the transaction to be in the best interests of the company and its shareholders and (v) if the related party is a director or an immediate family member of a director, the effect that the transaction may have on a director’s status as an independent member of the board and on his or her eligibility to serve on the board’s committees. Management will present to the audit committee each proposed related party transaction, including all relevant facts and circumstances relating thereto. Under the policy, we may consummate related party transactions only if our audit committee approves or ratifies the transaction in accordance with the guidelines set forth in the policy. The policy does not permit any director or officer to participate in the discussion of, or decision concerning, a related party transaction in which he or she is the related party.
We are not prohibited from paying any fees (including advisory fees), reimbursements or cash payments to our sponsor, officers, directors or members of our advisory board, or any of our or their affiliates, for services rendered to us prior to or in connection with the completion of our initial business combination, including the following payments, all of which, if made prior to the completion of our initial business combination, will be paid from funds held outside the trust account:
•
Reimbursement for office space, administrative services and compensation for officer time made available to us by Dominari, in an amount equal to $20,000 per month;
•
Payment of consulting, success or finder fees to our sponsor, officers, directors, advisory board members, or any of their respective affiliates in connection with the consummation of our initial business combination;
•
We may engage our sponsor or an affiliate of our sponsor as an advisor or otherwise in connection with our initial business combination and certain other transactions and pay such person or entity a salary or fee in an amount that constitutes a market standard for comparable transactions;
•
Reimbursement for any out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination; and
•
Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $2,500,000 of such loans may be convertible into private units of the post-business combination entity at a price of $10.00 per unit at the option of the applicable lender. Such units would be identical to the private units. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans.
39

TABLE OF CONTENTS

HOUSEHOLDING OF PROXY MATERIALS
The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Notices of Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more shareholders sharing the same address by delivering a single proxy statement or other Annual Meeting materials addressed to those shareholders. This process, which is commonly referred to as “householding,” potentially means extra convenience for shareholders and cost savings for companies.
This year, a number of brokers with account holders who are New America shareholders will be “householding” the Company’s proxy materials. A single proxy statement and proxy card will be delivered to multiple shareholders sharing an address unless contrary instructions have been received from the affected shareholders. Once you have received notice from your broker that they will be “householding” communications to your address, “householding” will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in “householding” and would prefer to receive a separate proxy statement, please notify your broker or New America. Direct your written request to New America Acquisition I Corp., 725 Fifth Avenue, 22nd Floor, New York, New York 10022, Attention: Secretary, telephone (917) 576-6828. Shareholders who currently receive multiple copies of the proxy statement at their addresses and would like to request “householding” of their communications should contact their brokers.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public at the SEC’s website at www.sec.gov. If you would like additional copies of this proxy statement or have questions about the Proposals, please contact the Company at the address above. To receive timely delivery of documents before the Annual Meeting, you must request them no later than December 15, 2026.
40

TABLE OF CONTENTS

OTHER MATTERS
The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying Proxy Card to vote on such matters in accordance with their best judgment. Our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 is being made available to shareholders together with this Proxy Statement, as required by Rule 14a-3(b) under the Exchange Act, and may be obtained without charge by written request to our Corporate Secretary at the address above.
FORWARD-LOOKING STATEMENTS
This Proxy Statement contains a number of “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, which are intended to be covered by the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates, projections and beliefs, as well as a number of assumptions concerning future events. When used in this Proxy Statement, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors discussed in “Risk Factors” and elsewhere in the Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.
Forward-looking statements speak only as of the date of this Proxy Statement. Except as required by law, we undertake no obligation to update any forward-looking statement.
41

TABLE OF CONTENTS

ANNEX A
 
ARTICLES OF AMENDMENT
TO
SECOND AMENDED AND RESTATED
ARTICLES OF INCORPORATION
OF
NEW AMERICA ACQUISITION I CORP.
 
      , 202 
Pursuant to the provisions of Section 607.1006, Florida Statutes, New America Acquisition I Corp., a Florida corporation (the “Corporation”), adopts the following amendments to its Second Amended and Restated Articles of Incorporation:
1. The Articles of Incorporation of the Corporation were filed on May 28, 2025 and assigned document number P25000031561.
2. The Articles of Incorporation of the Corporation were subsequently amended, most recently by the filing of Second Amended and Restated Articles of Incorporation (the “Second A&R Articles”) on December 3, 2025.
3. Section 9.1(b) of the Second A&R Articles is hereby amended and restated in its entirety to read as follows:
“Section 9.1 General
(b) Except for the withdrawal of interest to pay taxes (less up to $100,000 interest to pay dissolution expenses), none of the funds held in the Trust Account (including the interest earned on the funds held in the Trust Account) will be released from the Trust Account until the earliest to occur of (i) the completion of an initial Business Combination, (ii) the redemption of 100% of the Offering Shares (as defined below) if the Corporation is unable to complete its initial Business Combination by June 3, 2028 (December 3, 2028 if the Corporation has executed a definitive agreement for an initial Business Combination by June 3, 2028) or, if the Office of the Florida Department of State, Division of Corporations shall not be open for business (including filing of corporate documents) on such date the next date upon which the Office of the Florida Department of State, Division of Corporations shall be open (the “Deadline Date”) and (iii) the redemption of shares in connection with a vote seeking (a) to modify the substance or timing of the Corporation’s obligation to redeem 100% of such shares if the Corporation has not consummated an initial Business Combination by the Deadline Date or (b) with respect to any other provisions relating to shareholders’ rights or pre-initial Business Combination activity (as described in Section 9.7).”
4. These Articles of Amendment to Second Amended and Restated Articles of Incorporation shall become effective on the date of filing with the Florida Department of State.
5. The amendments were adopted by the shareholders on    , 202 . The number of votes cast for the amendments by the shareholders was sufficient for approval.
A-1

TABLE OF CONTENTS

IN WITNESS WHEREOF, the Corporation has caused these Articles of Amendment to be duly executed and acknowledged in its name and on its behalf by an authorized officer as of the date first set forth above.
 
 
 
 
 
 
 
NEW AMERICA ACQUISITION I CORP.
 
 
 
 
 
 
 
 
 
 
By:
 
 
 
 
 
 
Name:
 
 
Kyle Wool
 
 
 
Title:
 
 
Chief Executive Officer
 
 
 
 
 
 
 
[Signature page to Articles of Amendment to Second Amended and Restated Articles of Incorporation]
A-2

TABLE OF CONTENTS


 

TABLE OF CONTENTS


 

TABLE OF CONTENTS


 

TABLE OF CONTENTS


 
PRE 14A 0002074878 false 0002074878 2025-05-28 2025-12-31

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

INLINE XBRL TAXONOMY EXTENSION - SCHEMA

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: ny20084532x1_pre14a_htm.xml